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Abstract 
 
 
A survey of 9884 sheep (6560 live at animal markets and 3324 slaughtered  
 
in Nyala slaughterhouse ) and  4634 goats (4450 live at animal markets and  
 
184 slaughtered in Nyala slaughterhouse)   was carried out in South Darfur 
 
State, west Sudan, to determine the prevalence of caseous lymphadenitis   
 
which was 0.6% in live and 1.7% in slaughtered sheep, whereas it was 0.6%  
 
in live and 2.7% in slaughtered goats.
     The distribution of 141 lesions in lymph nodes of slaughtered and live  
 
sheep was 50.4 %  in  prescapular, 14.9 % in parotid, 11.3% in precrural,  
 
5.7% in mandibular, 3.5% in supramammary, 0.7% in mediastinal, 
 
and 0.7% in mesenteric lymph nodes. Lesions in other parts of the body  
 
were 11.3% subcutaneous abscesses, 0.7% abscess in a liver, and 0.7%  
 
abscess in lung.  The  distribution of 44 lesions in lymph nodes of live and  
 
slaughtered goats was 43.2 % in prescapular, 27.3% in parotid, 11.4 % in  
 
mandibular and 9.1% in precrural lymph nodes. In other parts 9.1%   
 
subcutaneous abscesses were noted in goats.  
   
   Mass culture of a local strain of Corynebacterium  pseudotuberculosis  
 
CP41 N was obtained using IBT bioreactor at pH 8, temperature 31 ℃  
 
and dilution rate of 0.02 h
-1
 . The harvest was used to prepare five types of 
 v 
 
vaccines; The first a cell wall vaccine containing 6mg/ 1 ml of protein, the  
 
second a whole cell vaccine containing 16mg/ 1ml of bacterial dry weight,  
 
the  third a toxoid vaccine containing 8 mg/1 ml of protein the fourth a cell  
 
wall + toxoid vaccine (6mg/ 1ml+ 8mg/1ml) and the fifth a whole cell +  
 
toxoid vaccine (16mg/1ml + 8 mg/1ml). Saponin  and aluminum hydroxide  
 
adjuvants were added in a concenteration of 1mg/1ml to each of the different  
 
vaccines. A dose of 0.5 ml from the three first  vaccines and of 1ml from the  
 
fourth and fifth ones were injected subcutaneously to each one of 5 groups   
 
of sheep of  7  animals, and a sixth group was left as unvaccinated  control.  
 
   All animals were bled at weekly intervals. After one month a booster doses  
 
of the vaccines were given to the animals which were bled weekly for  
 
serological monitoring by the  agglutination test. All animals were  
 
challenged subcutaneously with 5.1X10
8  
CFU Corynebacterium  
 
pseudotuberculosis  CP41 N one month after the second dose of vaccine.  
 
The animals  were then slaughtered one month later to determine the number  
 
of abscesses in the carcasses.The results showed that the vaccine which  
 
consisted of whole cells + toxoid was the best of the five vaccines with a  
 
significant reduction  (p< 0.05) in mean abscesses numbers in vaccinated  
 
animals after challenge with C.pseudotuberculosis. The percentage of  
 
protection of the group vaccinated with the whole cell+ toxoid was 75%  
 vi 
 
compared with  32.3%, 37.5%, 37.5% and 45.3% for the groups vaccinated  
 
with cell wall, whole cell, toxoid and the cell wall + toxoid vaccines,   
 
respectively  
 
                       Sixty- six isolates of Corynebacterium pseudotuberculosis from the sheep 
                        
  and goats were tested for their sensitivity to 16 antimicrobial agents. The  
 
isolates were found highly sensitive to nitrofurantoin, chloramphenicol,   
 
rifampacin, cotrimoxazole, erythromycin, and ampicillin. Moderately  
 
sensitive to methicillin, kanamycin, gentamycin and tetracycline, but were   
 
resistant to nalidixic acid, colistin, novobiocin, penicillin, cloxacillin and  
 
streptomycin. 
 
PCR technique was used to examine 28 of the local isolates of  
 
Corynebacterium pseudotuberculosis using the primer targeting the 16S  
 
rRNA gene. The results  showed homogeneity of the isolates with the  
 
molecular size of this gene. 
  
        The study showed that caseous lymphadenitis is prevalent in South  
 
Darfur State, which is an important area for sheep production in the country.  
 
    A vaccine consisting of whole cell+toxoid appears to be promising for  
 
protection against the disease, examination of this vaccine under field  
 
conditions is recommended.    
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 1 
Introduction 
 
 
        Sudan is one of the largest African countries, with high agricultural  
 
potentialities and large livestock population. Under the present food  
 
crisis in the world, it is expected that the country  will participate in 
 
filling  the food shortage gap. Animal diseases are the main constrain facing  
 
livestock development. One of these diseases is caseous lymphadenitis  
 
(CLA) that caused by Corynebacterium pseudotuberculosis(C.  
 
pseudotuberculosis). The disease mainly affects sheep and goats and is  
 
world wide (Batey, 1986; Campell, 1982; Hein and Cargill, 1981; Lund et  
 
al.,1982). In Sudan the disease causes great economic losses due to  
 
condemnation of affected carcasses and because it affects live sheep and  
 
goats trade with the neighboring gulf states.  
 
  The disease is characterized by abscess formation in lymph nodes mainly  
 
and the internal organs. Once the disease is endemic, it is very difficult to  
 
eradicate (Brown and Olander, 1987). Antibiotics therapy is generally not  
 
effective as antimicrobial drugs are unable to penetrate  the caseuated lymph  
 
nodes and abscesses.Control programmes usually entail culling of animals  
 
with recurring abscesses, isolation of affected ones, and lancing of  
 
abscesses.  
 
 2 
    Identification of infected animals is often difficult as internal abscesses,  
 
especially those of lungs, escape detection (Ellis et al., 1987) while external  
 
abscesses are difficult to detect in sheep carrying a full fleece. Vaccination  
 
against the disease seems to be the most practical measure to help in  
 
preventing the disease (Brown et al., 1986). 
 
   The objectives of this study were to:  
 
1-   Determine the prevalence of CLA in sheep and goats in South  
 
      Darfur State as it one the main areas of production. 
 
2-   Apply  PCR technique for identification of C.pseudotuberculosis            
 
isolates obtained during the study 
 
3-   Utilize IBT bioreactor  for obtaining mass culture of C.           
       
    pseudotuberculosis for vaccine production. 
       
  4-   Prepare different vaccines to be evaluated for protection 
 
                 against CLA. 
 
5-  Determine the susceptibility of C. pseudotuberculosis strains isolated  
 
     during the course of the study to various  antibiotics . 
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Chapter One 
 
Literature Review 
 
1.1. Caseous lymphadenitis in sheep and goats: 
 
   Caseous Lymphadenitis is a disease of sheep and goats. Though C.  
 
pseudotuberculosis was originally identified as the causative microorganism 
 
of CLA in sheep and goats, this bacterium has also been isolated from other 
 
species, including horses, cattle, camels, swine, buffaloes, and humans  
 
(Yeruham et al., 1996; Peel et al., 1997; Selim, 2001; Williamson,  
 
2001). The disease is characterized by suppuration of large lymph  
 
nodes, usually the superficial ones, but the internal nodes may also be  
 
involved in severe visceral forms of the disease(Woodruff and  
 
Greogory, 1929; Maddy, 1953; March, 1965; Knight, 1969; Nairn and  
 
Robertson, 1974; Muckle and Gyles, 1982, 1983; Muckle et al., 1992; Pepin  
 
et al., 1999; O’Doherty et al., 2000; Williamson, 2001) 
 
1.1.1. Clinical picture of caseous lymphadenitis: 
 
           It was stated that, signs of infection with the CLA appear slowly and  
 
sheep might be infected for years before clinical signs are evident (Lovell,  
 
1969). The   internal form of the disease is the most severe form. 
 
    Abscessation may involve internal organs, commonly lungs, liver and  
 
Kidneys and their adjacent lymph nodes. Internal CLA may cause  
 4 
emaciation and  thin ewe syndrome and is often responsible for carcass  
 
condemnation after slaughter and inspection (Renshaw et al., 1979).  
 
External and internal forms may develop together. Different authors  
 
reported various observations on CLA infections thus, depending on the  
 
frequency of occurrence of infected lymph nodes, Woodruff and Oxer  
 
(1929) mentioned that the prescapular and the prefemoral lymph nodes  
 
were the most common sites. The lungs and their associated lymph nodes,  
 
the bronchial and mediastinal, were next. They found that lymph nodes of  
 
the upper part of the alimentary tract, and the parotid were not commonly  
 
affected. The mesenteric lymph nodes were even less commonly affected. It  
 
was stated that lymph nodes most commonly affected were bronchial,  
 
mediastinal, precrural, hepatic, supramammary, scrotal and popliteal  
 
(Maddy, 1953). Yet it was found that the most affected lymph nodes in  
 
order of frequency were the prescapular, prefemoral, superficial inguinal,  
 
ischiatic and popliteal. However, it was reported that the affected lymph  
 
nodes in order of frequency of infection were prescapular, prefemoral,  
 
popliteal, mediastinal and in very rare cases the renal (Gameel, 1974). It  
 
was observed that the lesions were mainly found in the prescapular,  
 
precrural, mediastinal, bronchial and subiliac lymph nodes( Ayers, 1977).  
 
Further more, it was reported that the prescapular, prefermoral, internal  
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iliac, mediastinal and bronchial lymph node and lungs were commonly  
 
affected (Williamson and Narin, 1980). On the other hand it was found that  
 
the lesions were mainly in the prescapular and precrural lymph nodes and in  
 
the adjacent subcutaneous tissues, in addition to the lungs parenchyma  
 
(Kuria and Nagatia, 1990). In the same time it was reported that the  
 
precrural, prescapular and popliteal lymph nodes were frequently affected,  
 
whereas the visceral lesions were commonly found in the lungs (Gilmour,  
 
1990). Then again it was  reported  that lesions in the infected animals were  
 
mostly located in   the    prescapular, precrural, supramammary, inguinal  
 
and popliteal lymph nodes respectively. In severe caseous inflammatory  
 
processes, besides lymph nodes, lesions were found in lungs, heart, liver,  
 
spleen and peritoneum as well (Musa, 1998). Then it was reported that  the  
 
distribution of lesions in carcases at Nyala slaughterhouse in the parotid,  
 
prescapular, precuraral, mandidular, popliteal and inguinal lymph nodes  
 
besides pyogenic lesions in the lungs and scrotal fascia (Elgaddal, 1997).    
 
             1.1.2. Geographic  distribution of caseous lymphadenitis :    
 
             Caseous lymphadenitis in sheep and goats is prevalent in most parts of  
 
the world (Brown and Olander,  1987), especially in the areas where intensive  
 
sheep and goats industry is practiced. In  Australia data gathered from abattoirs  
 
about prevalence were as high as 58% (Williamson  and Nairn, 1980). In the  
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western United States, surveys revealed that it is the third  leading cause for  
 
condemnation of sheep at slaughter, following emaciation and pneumonia  
 
(Maddy, 1953). In the Sudan, CLA in sheep was  reported for the first time by  
 
Carr (1914) in Sennar. The disease was described as painless  swelling and the  
 
causative agent as slender non-motile rods: the Priesz-Nocard Bacillus. The   
 
affected sheep were otherwise normal (Carr, 1914).   
 
1.1.3. The causative agent of the disease: 
 
1.1.3.1    History: 
 
            Corynebacterium pseudotuberculosis is the causative  
 
organism of CLA. Nocard  isolated the organism for the first time in 
 
 1888 (Nocard 1889). The same organism was isolated and named   
 
Bacillus pseudo-tuberculosis ovis  ( Priesz, 1894). Then it was included  
 
it in the genus Corynebacterium, the generic name they introduced  for  
 
diphtheria bacillus and diphtheroid and given the name  
 
Corynebacterium   pseudotuberculosis  ovis (Lehman and Neuman,   
 
1896). The organism was named Corynebacterium   ovis (Bergy,  
 
1923). The name Corynebacterium ovis was criticized  because of its   
 
occurrence in animals other than sheep and suggested the name  
 
Corynebacterium  pseudotuberculosis (Carne, 1939), which was  
 
adopted in the sixth edition of Bergy's manual (1948). 
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1.1.3.2. Taxonomy: 
 
The genus Corynebacterium is one of the largest genera in the  
 
coryneform group. It accommodates the diphtheria bacillus and some  
 
other species pathogenic to animals. Bergey’s Manual of Systematic 
 
 Bacteriology listed only 17 Corynebacterium species; however, 11  
 
new species were defined between 1987 and 1995 ( Funke et al., 1997)  
 
and another 32 new species were described between 1996 and 2003.  
 
From 2001 to 2003, up to 13 new species were validly published   
 
(http://www.bacterio.cict.fr/c/corynebacterium.html). At present the  
 
genus Corynebacterium contain more than 60 species, the vast  
 
majority of which have been isolated from human or animal samples.  
 
Chemotaxonomically, this genus includes species that possess wall  
 
chemotype IV( arabinose, galactose, and meso-diaminopimelic acid  
 
(meso-DAP), short-chain mycolic acids (corynomycolic acids,  
 
approximately from 22 to 36 carbon atoms) and DNA G + C contents  
 
ranging from 51 to 63 mol% ( Funke et al., 1997) . The narrower  
 
definition of the genus Corynebacterium  has resulted in the transfer of  
 
several species (Clavibacter, Rhodococcus, and Turicella) were  
 
classified as other genera.   
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 1.1.3.3. Corynebacterium and other similar genera: 
  The genus Corynebacterium was often grouped with 
Mycobacterium, Nocardia and    Rhodococcus based on lipid content of 
their cell walls as CMNR-group (Brown and Olander, 1987). The guanine 
+ cytosine content of the DNA of   Corynebacterium is similar to that of 
the other mycolic acid-producing bacteria, Mycobacterium (62-70%)  
Nocardia (60 to 69%), Rhodococcus (59 to 69%)Gordona (63 to 69%) 
Dietzia (63 to 69%) and Tsukamurella (67 to 68%). This similarity may 
strengthen the consolidation of these genera into one family (Wayne and 
Kubica, 1986). The differences of true Corynebacterium from the genera 
Mycobacterium and Nocardia in addition to that they possessed a G + C 
rich DNA, they also contained N- glycol residues in glycan moiety of 
their cell wall (Collins and Cummins, 1986). On the other hand, 
differentiation of true corynebacteria from certain rhodococci could not be 
done by the analysis of mycolic acid alone. For instance representatives of 
the genus Rhodococcus were described as aerobic, although the true 
corynebacteria were undoubtfully facultative anaerobic (Goodfellow and 
Alderson, 1977). Furthermore, members of the genus Rhodococcus 
possessed 10- methyloctadecanoic acid (tuberculostearic), whereas true  
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corynebacteria lacked this fatty acid (Collins, Goodfellow and Minnikin,  
1982).  
1.1.3.4. Animal diseases caused by C. pseudotuberculosis:   
C. pseudotuberculosis has been isolated from abscesses and 
suppurative lesions, in sheep and goats where it causes CLA. Woodruff and 
Gregory (1929) stated that it produced characteristic abscesses in lymph 
nodes. Usually the large superficial nodes were affected, but internal nodes 
may also be involved in severe visceral form of the disease. 
Horses are the third species that is affected. The same organism causes 
ulcerative lymphangitis. This is an excoriating, suppurating inflammation of 
the lymphatics usually confined to the distal portion of the limb. A disease 
of horses recognized to be caused by C.pseudotuberclosis is the syndrome 
of chronic ventral abscesses reported in western United States (Hughes and 
Biberstein, 1959). 
         An outbreak of C.pseudotuberclosis infection in camels (Camelus  
 
dromedarius) in Saudi Arabia was reported (Radwan, El Magawry; Hawari;  
 
Albekairi; and Rebleza,1989). The authors postulated that the disease had  
 
spread from sheep and goats, which shared pastures with the camels. Also an  
 
outbreak of natural C.pseudotuberculosis infection in adult camel herds  
 
 in Jordan was described and reported for the first time (Hawari, 2008). 
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      Human infection caused by C. pseudotuberculosis is a rare event, and  
 
most of the reported cases have been related to occupational exposure; one  
 
case,  involved the ingestion of raw goat meat and cow milk (Peel et al.,  
 
 1997).  About 25 cases of infection of humans with this microorganism 
 
 have been reported in the literature ( Mills et al., 1997; Peel et al., 1997;  
 
Liu et al., 2005).  Peel et al. (1997)  reviewed 22 cases, in which infected  
 
humans were generally presented with lymphadenitis, abscesses, and  
 
constitutional symptoms. Mills et al. (1997) described suppurative  
 
granulomatous lymphadenitis in a boy, due to contact with contaminated  
 
farm animals. Liu et al. (2005) reported C.pseudotuberculosis infection in a  
 
patient’s eye, due to an occular implant. In most cases, the patients received  
 
antibiotic therapy and the affected lymph nodes were surgically removed  
 
(Mills et al.,1997; Peel et al.,1997; Liu et al., 2005  ). 
 
1.1.3.5. Morphology of C. pseudotuberculosis : 
 
   Breed, Murry and Smith (1957) described C. pseudotuberculosis as slender  
 
rods,  measuring 0.5-0.6 by 1-3 µm, it appears as a coccus or cocco-bacillus,  
 
non- motile and non-sporulating and non-capsulating.  
 
          In a liquid culture, the organism shows less pleomorphism than in a  
 
fresh material from a natural infection and dominant forms being short  
 
cocco-bacilli. In older cultures, bacillary and rarely filamentous forms have  
 
 11 
been observed, but forms with club-headed ends and tapering blunt ends have  
 
also been described (Carne, 1939). 
 
   Breed et al. (1957) described the organism as staining irregularly Gram  
 
positive. Carne (1939) and Purchase (1944) found that the bacilli might  
 
have a number of transverse striations and granules, which were best seen  
 
by Neissler's stain. They have also found that the organism was non-acid  
 
fast, although Carne found that it was necessary to use 5% sulphuric acid to  
 
decolorize some strains grown in milk. 
     
    Hard (1969) examined C. pseudotuberculosis by electron microscope and  
 
found an electron dense follicular layer external to the cell wall and using  
 
ligroin and acetone methanol extractions, he had demonstrated lipid on the  
 
surface. 
 
1.1.3.6. Cultural characteristics:  
 
        C. pseudotuberculosis is a facultative anaerobe which grows poorly on  
 
ordinary solid media and its growth is greatly improved by addition of  
 
blood or serum. The colonies on blood agar are yellowish-white,  
 
opaque flat with a matt surface after 24 to 48 hours incubation at 37°C. The  
 
colonies are surrounded by a narrow zone of beta-haemolysis. In primary  
 
cultures, it produces clear minute colonies (Daines and Austin, 1932).  
 
Because of the high lipid content, the cell wall lipids constitutes as much as  
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13.3% of the dry weight of the bacterial cell wall (Ioneda and Sliva, 1979),  
 
accordingly the colonies appear waxy, splatter in flame and can easily be  
 
pushed across the agar surface. In liquid media   the growth is scanty with  
 
slight pellicle and this was attributed to the hydrophobic nature of the outer  
 
lipid layer ( Brown and Olander, 1987). 
 
1.1.3.7. Identification and characterization: 
 
1.1.3.7.1. Biochemical properties: 
1.1.3.7.1.1. Nitrate reduction: 
Wholfeil and Weiland (1937) reported that the organism reduced 
nitrates to nitrites but Wilson and Miles (1964) found that nitrate was 
reduced by some but not all strains. It was reported that 21- 79% of the 
strains reduced nitrates to nitrites ( Cowan, 1974). Biberstein et al. (1971) 
stated that strains from horses were able to reduce nitrates to nitrites while 
those from sheep and goats did not. Muckle and Gyles (1982) examined 25 
strains of caprine origin; they all failed to reduce nitrate. Barakat et al. 
(1984) and Brown and Olander (1987) reported that strains isolated from 
small ruminants tended not to reduce nitrate, whereas those isolated from 
horses did, and they suggested that this criterion could be used for 
biotyping. Restriction endonuclease assays were performed on few strains 
and this revealed restriction patterns that correlated with the ability or 
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inability of the isolates to reduce nitrate (Groman et al., 1984). The work of 
Groman et al. (1984) was confirmed (Songer et al., 1988) by existence of 
two biovars of the organism, they have suggested biovar ovis, for the 
nitrate-reductase negative strains and biovar equi for those that were 
nitrate-reductase positive. 
1.1.3.7.1.2. Urease and catalase production: 
 It was stated that C.pseudotuberculosis was capable of hydrolyzing 
urea and producing catalase enzyme (Cowan, 1974). It was reported that 
many strains could hydrolyze urea (Hughes and Biberstein, 1959; Dennis 
and Bamford, 1966; Muckle and Gyles, 1982). It was mentioned that 
attenuated strains of C.pseudotuberculosis were urease negative (Burrel, 
1979). It was accepted that C.pseudotuberculosis is catalase positive 
(Cowan, 1974; Songer  et al.,1988). 
1.1.3.7.1.3. Fermentation of carbohydrates:    
C.pseudotuberculosis, like other cornynebacteria produce acid but no 
gas from fermentable carbohydrates. Acids are produced from glucose, 
maltose, galactose, fructose and mannose. Variable results were reported 
from sucrose, lactose, xylose, dextrin, arabinose, mannitol and glycerol 
(Collins and Cummins, 1986). It was mentioned that C.pseudotuberculosis 
strains were positive to glucose, sucrose and maltose, negative to trehalose 
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and salicin, variable results to lactose ( Barrow and Feltham, 1993). 
1.1.3.7.1.4. Other biochemical properties:  
Cowan (1974) reported that C.pseudotuberculosis did not produce H2S, 
in contrast to Dennis and Bamford (1966) who reported variable results.  
Carne (1939) found slight liquefaction of gelatin. In contrast, Hughes 
and Biberstein (1959) examined eight strains and all were found positive. 
Variable results of gelatin liquefaction were reported (Barrow and 
Feltham,1993). 
Dennis and Bamford (1966) reported variable results for methyl red 
test. However, Collins and Cummins (1986) stated that the organism was 
positive for methyl red. 
C.pseudotuberculosis does not produce indole (Dennis and Bamford, 
1966;  Cowan, 1974; Songer et al., 1988). 
1.1.3.7.2.  API Coryne system: 
A biochemical test for coryneform bacteria identification  the API Coryne  
 
system (API-bioMérieux, Inc., La Balme les Grottes, France) was  
 
established ( Dorella, 2006). This system consists of 21 biochemical tests  
 
which can be performed in 24–48 h. The test contains 20 tubes containing  
 
substrates that allow for 11 enzyme tests (pyrazinamidase, pyrrolidonyl  
 
arylamidase, β-galactosidase, alkaline phosphatase, α-glucosidase, 
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 Nacetylglucosaminidase, β-glucuronidase, and nitrate reduction and gelatin,  
 
urea and esculin hydrolysis) and eight carbohydrate fermentation tests  
 
(glucose, ribose, D- xylose, mannitol, maltose, lactose, sucrose and  
 
glycogen). This system was found more reliable and rapid when it is  
 
compared with standard identification methods (API-bioMérieux, Inc.). 
 
          1.1.3.7.3. Genetic characterization: 
 
          Genetically, for characterization of  C. pseudotuberculosis Songer et al. 
 
 (1988) reported correlation between restriction enzyme analysis (REA) of  
 
chromosomal DNA profile and ability or  inability of isolates to reduce nitrate, but  
 
numerous  bands generated by this technique made interpretation of the results  
 
difficult. Sutherland et al. (1996) used restriction fragment length polymorphism  
 
(RFLP), they only managed to detect the differences between nitrate-positive and  
 
nitrate  negative groups by this technique. Literack et al. (1999) tested eight  
 
isolates and  two reference strains for biomedical reactions, antibiotics  
 
susceptibility, production of phospholipase D, and restriction endonuclease profile  
 
and ribotyping. Both phenotypic and genotypic properties of the tested and  
 
reference strains were identical,  and all of them were identified as C.  
 
pseudotuberculosis. Conner et al. (2000) characterized 50 isolates from sheep  
 
and horses, an original goat outbreak strain and  a type strain by biotyping,  
 
antimicrobial susceptibility, production of phospholipase D (PLD), and   
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genotypically by pulsed-field gel electrophoresis using SFIL and SMAL  
 
 endonucleases. All the isolates were confirmed as C. pseudotuberculosis, and all   
 
produced PLD but none reduced nitrate. Restriction with SfiI generated 16 – 18  
 
bands  between  48.5 and 290 kb and differentiated six pulsotypes. 
 
More recently, analysis of partial gene sequences from the -subunit of  
 
RNA polymerase (rpoB) has been shown to be more accurate for the  
 
identification of Corynebacterium species than analyses based on 16S  
 
rDNA (Khamis et al. , 2004; 2005). This method  has also been successfully  
 
used to identify mycobacterial species (Kim et al.,  1999).  Although the rpoB  
 
gene is a powerful identification tool, many authors propose that it may be used to  
 
complement the 16S rRNA gene analysis in the phylogenetic studies of  
 
Corynebacterium and Mycobacterium species (Mollet et al., 1997; Kim et  
 
al., 1999;Khamis et al., 2004; 2005). Dorella et al. (2006) constructed a  
 
phylogenetic tree based on rpoB gene sequences of reference strains from  
 
the CMN group. Based on this phylogenetic tree, they could observe a clear  
 
relationship between C. pseudotuberculosis and C. ulcerans. Moreover,  
 
analysis using the rpoB gene allowed the identification of the group that  
 
these two species belong to, as previously observed by Khamis et al. (2004;  
 
2005).  
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1.1.3.7.4. Polymerase Chain Reaction (PCR): 
     Çetinkaya  et al. (2002) carried out a study to estimate prevalence of 
caseous lymphadenitis (CL) in sheep and goats slaughtered at a local 
abattoir in Turkey. A total of 2046 sheep and 2262 goat carcasses were 
examined during the study period and 118 lymph nodes with abscesses, 89 
from sheep and 29 from goats, were collected. Corynebacterium 
pseudotuberculosis strains were isolated from 81.4% of the abscesses, 
giving an overall prevalence of 2.2%. The prevalence was 3.5 and 1.1% in 
sheep and goats, respectively. PCR on DNA extracted from 96 suspicious 
isolates, using a pair of Corynebacterium pseudotuberculosis-specific 
primers, was positive for 93. Although cross-reaction with C. ulcerans, a 
human/bovine species, was observed, the PCR assay used in this study may 
successfully be applied for the diagnosis of CL in goats and sheep as  an 
alternative to conventional methods, owing to its advantages of specificity 
and speed. Pacheco et al. (2007)
   
in an effort to facilitate C. 
pseudotuberculosis detection, developed a multiplex PCR (mPCR) assay 
targeting three genes
 
of this bacterium: the 16S rRNA, rpoB and pld genes. 
This method 
 
allowed efficient identification of 40 isolates of this bacterium
 
that had been identified previously by biochemical tests. 
 
Analysis of 
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taxonomically related species did not generate the
 
C. pseudotuberculosis 
mPCR amplification profile, thereby demonstrating
 
the assay's specificity. 
As little as 1 pg of C. pseudotuberculosis
 
genomic DNA was detected by 
this mPCR assay, demonstrating the
 
sensitivity of the method. The detection 
limit in clinical samples
 
was estimated to be 10
3
  CFU/ml 
C.pseudotuberculosis could
 
be detected directly in pus samples from 
infected sheep and
 
goats (n=56) with a high diagnostic sensitivity (94.6 %). 
The
 
developed assay significantly improves rapid C. pseudotuberculosis
 
detection and could supersede bacteriological culture for microbiological
 
and epidemiological diagnosis of CLA. 
1.1.3.8.  Haemolysis: 
 
Variable degrees of haemolysis on blood agar plate culture were observed (Hall  
 
and Stone, 1916; Minnet, 1922; Carne, 1939; Dhanda and Singh, 1955; Fraser,  
 
1961; Zaki, 1965;  Lovell and Zaki, 1966; Lovell, 1969). Minnet (1922) reported  
 
that nine out of ten strains produced a narrow zone of haemolysis while one strain  
 
of low virulence did not. It was found that some strains produced beta haemolysis,  
 
some partial haemolysis and some no haemolysis on 10% defibrinated sheep  
 
blood agar (Carne, 1939). A weak haemolysis was observed on blood agar plates  
 
(Dhanda and Singh, 1955). Lovell (1969) stated that the organism produced a  
 
haemolysin. A synergestic haemolytic effect of mixed culture of  
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C.pseudotuberculosis and C. equi was observed on sheep, goats, ox and rabbit, but  
 
not on horse blood (Fraser, 1961). 
 
It was  found that sterile supernatant of digest broth culture of toxigenic strains  
 
had haemolytic activity on blood agar plates ( Zaki, 1965; Lovell and Zaki, 1966).  
 
Hall and Stone (1916) mentioned that haemolysis was inhibited by the presence of  
 
fermentable carbohydrates, while Carne (1939) found that glucose did not, and  
 
that 10% carbon dioxide had no influence on haemolysin production but  
 
anaerobiosis favoured it. It was stated that haemolysis was a separate activity of  
 
the bacterial cell and was not associated with the filterable toxin (Lovell, 1969). 
 
1.1.3.9.  Toxin Production:  
 
C.pseudotuberclosis produces an exotoxin in vitro. Carne (1939) and Purchase  
 
(1944) described a condition which was characterized by haemolysis of red blood  
 
cells after incubation of sheep blood with liquid cultures of virulent  
 
C.pseudotuberclosis. Lovell and Zaki (1966) mentioned that not all of their strains  
 
produced a toxin while Rottgardt (1930) stated that all his isolates formed a toxin.  
 
It was  observed that toxins produced by different strains were similar (Doty et  
 
al.,1964). However, not all strains were equally potent toxin producers (Daines  
 
and Austin, 1932) and there was loss of toxicity by some of the strains. Rottgardt  
 
(1930) and Carne (1940) described a technique for the production of high  
 
concentration of the exotoxin in vitro which was associated with pellicle  
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formation in liquid cultures. The toxin was stable in liquid form but inactivated by  
 
heat at 60℃ for 10 minutes, 37℃ for two weeks or 25℃ for three months and by  
 
prolonged storage, in acidic environment of pH less than 5 or by formalinization.  
 
Observations revealed that the action of toxin was on the walls of blood vessels.  
 
Jolly (1965), after labelling plasma with Evans Blue observed areas of colouring  
 
at sites of intradermal inoculation of the toxin. It was also found that injection of  
 
the toxin into the vascular corneo-aclertic junction in sheep produced a severe  
 
local reaction similar to that seen in the skin. 
 
Soueek et al. (1971) reported that the toxin of  C.pseudotuberculosis was a  
 
phospholipase D acting on sphingomylin to produce N- acylsphingosyl phosphate  
 
(cermide phosphate) and choline.Zaki (1965) demonstrated that lysis of ox  
 
erythrocytes by Staphylococcus B-hemolysin could be inhibited by products of  
 
toxigenic strains of C. pseudotuberculosis. It was found that this inhibitory effect  
 
was paralleled with the toxicity as measured in vitro. The effect was believed to be  
 
the result of its action on sphingomyelin molecule, rendering them unsusceptible  
 
to subsequent attack by the phsopholipase of the Staphylococcus B- haemolysin.    
 
Onon (1978) using ammonium sulphate precipitation, purified the toxin to about  
 
400- fold to homogeneity and characterized it structurally to be a basic  
 
glycoprotein of molecular weight 14500 ± 1000 daltons with an amino acid  
 
composition of hydroxyproline, hydroxylisn and glycin, resembling that of  
 
 21 
collagen. 
 
  Burrell (1979) described the optimal conditions for the haemolytic 
activity of C.pseudotuberculosis exotoxin, and concluded that the exotoxin 
had a haemolytic activity at pH below 6 and RBCs adhesion activity at 
neutral or slightly alkaline pH. He also stated that the haemolytic substance 
passed through 0.22 μ filter, but was retained by Seitz (0.45 μ bore size) 
filtration. It was inactivated by heat and its activity was inhibited by 
immune serum. It was stated that haemoagglutination titre was closely 
related to haemolytic and dermonecrotic titres of C.pseudotuberculosis 
culture supernatant( Burrell, 1980c). He suggested that haemoagglutination 
was another activity of C.pseudotuberculosis exotoxin.  
 Alan et al. (1980) investigated, in vitro, the mechanism of synergistic 
lysis of sheep erythrocytes by C.pseudotuberculosis and C.equi 
(Rhodococcus equi).   They reported that haemolysis required: Firstly the 
action of phospholipase D from C.pseudotuberculosis, secondly the action 
of extracellular protein of C.equi, the third was the presence of magnesium 
ions. The extratcellular protein of C.equi  was purfied to homogeneity and 
was found to be phospholipase C capable of hydrolyzing cermide 
phosphate, and all of the isolated major phospholipids of mammalian 
erythrocyte membrane. Maximum lysis was found to require the imposition 
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on the system of a fourth condition, such as chilling. Mg ions were required 
in the first and second step. They inferred that sphingomyelin of sheep 
erythrocytes was first converted to cermide phosphate by C.equi  
phospholipase C, and the resultant, in situ, cermide then underwent 
dislocation by chilling and perhaps also by virtue of an affinity between 
cermide and C.equi phospholipase C, the dislocation of cermide presumably 
disorganized the lipid bilayer sufficiently to result in cell lysis. 
Sutherland, Sperijers and Andres (1989) compared the activity of 
exotoxin produced by four strains of C.pseudotuberculosis  according to 
their ability to kill white mice, haemolytic activity, Staphylococcus 
haemolysin-inhibitory effect and activity in an enzyme- linked 
immunosorbent assay (ELISA). They reported that exotoxin with 
haemolytic titre of 1: 256 or more, killed all mice and had the most 
inhibitory effect, (1: 64 or more) on Staphylococcus haemolysis-inhibiting 
titre. They did not find significant correlation between the ELISA and 
relative toxicity of the exotoxin. 
1.1.3.10.  Antimicrobial susceptibility tests: 
 
The susceptibility pattern of C. pseudotuberculosis to antimicrobial agents  
 
varies among isolates obtained from various sources (Conner et al., 2000;  
 
Foley et al., 2004). Isolates  of C. pseudotuberculosis  from human were  
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found susceptible to erythromycin and penicillin (Lipsky et al., 1982).  
 
  Muckle and Gyles (1982) in a study of 26 strains isolated from lesions of  
 
caseous lymphadenitis in goats, reported that all strains were susceptible to  
 
the antibiotics ampicillin, chloramphenicol, lincomycin, gentamicin,  
 
tetracycline, penicillin G and sulfamethoxazole-trimethoprim. Only three  
 
isolates were susceptible to neomycin, and all strains were resistant to  
 
streptomycin. Garg et al. (1985) reported that strains of  
 
C. pseudotuberculosis  were strongly resistant to penicillin but susceptible 
 
 to neomycin. A strain highly resistant to streptomycin (500 ug/mL) was  
 
observed in a study of 22 isolates of  C.pseudotuberculosis from sheep and 
 
 goats’ abscesses. Costa et al. ( 1998) reported that the minimal inhibitory  
 
concentrations (MICs) of 17 antimicrobial agents for C. pseudotuberculosis  
 
were similar to those described by others (Muckle and Gyles, 1982;  
 
Adamson et al., 1985; Prescott and Yielding, 1990; Judson and Songer,  
 
1991). They stated that the slight variation of MIC of some antimicrobial  
 
agents for isolates from small ruminants vs. horses and cattle has  
 
questionable clinical significance but may be yet another indication of  
 
differentiation between isolates obtained from different sources. 
 
However, Fernández et al. (2001) found higher MIC value for several  
 
antimicrobial agents in an analysis of corynebacteria isolated from ewe 
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 mastitis. Olson et al. (2002) grew C. pseudotuberculosis as a biofilm, in an  
 
attempt to reproduce the environment of a natural infection. They observed  
 
that this bacterium was highly resistant to all the drugs that they tested  
 
under such growth conditions. 
 
1.4. Pathogenesis: 
Infection of superficial wounds with C.pseudotuberculosis represented 
the initial events in pathogenesis of CLA, followed by spread of infection to 
the regional lymph nodes which subsequently suppurate (Maddy, 1953; 
Jubb and Kennedy, 1970; Kimberling, 1988). It is apparent that two factors 
play essential roles in development of the disease. First, The high lipid 
content of the outer cell wall layer of C.pseudotuberculosis allows  the 
organism to resist digestion by cellular enzymes and persist as facultative 
intracellular parasite. Hard (1972) examined the toxic effect of   a petrol-
ether lipid extracted from the surface coat of C.pseudotuberculosis on 
peritoneal macrophages in a mouse, a rabbit and a guinea pig. He 
investigated cytotoxicity, viability assayed by dye exclusion, glycolytic 
activity and  ultrastructural morphology. The viability test demonstrated a 
lethal effect on normal and immune mouse macrophages but not on those of 
the rabbit or guinea pig. Measurement of glycolysis indicated a significant                           
degree of cytotoxicity in normal mouse macrophage ingesting lipid, a 
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nonsignificant depression of activity in cells from immune mice, and no 
alteration in the activities of rabbit and guinea pig macrophages. Electron 
microscopy demonstrated that C.pseudotuberculosis surface lipid caused 
acute lethal injury in normal and immune mouse macrophages. Tashijian 
(1983) showed in an electron microscopic study using caprine mammary 
macrophages, that C.pseudotuberculosis remained viable within 
macrophages. Fusion of phagosomes was documented by histochemical 
localization of acid phosphatase. Despite this fusion, the organism survived 
and the caprine macrophages which underwent progressive degeneration 
and died within twenty hours. It is this ability of C.pseudotuberculosis 
which resists digestion by phagocytes that results in the eventual formation 
of abscess. The virulence of a particular strain may be related to the amount 
of cell wall lipid. The amount of surface lipids has been shown to be greater 
in more pathogenic strains (Muckle and Gyles, 1984). McKean et al. (2007) 
stated that the expression of PLD by intracellular C. pseudotuberculosis 
was shown to play a small but significant role in the reduction of 
macrophage viability following infection. They demonstrated  that the 
regulation of C. pseudotuberculosis PLD is complex. This regulatory 
complexity may play an important role in allowing the pathogen to 
successfully adapt to the changing host environment during infection, 
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migration, establishment and disease progression. 
Production of an exotoxin is the second important component of the 
pathogenic mechanisms of C.pseudotuberculosis. The toxin was initially 
isolated by Carne (1940), who described its physical properties and 
investigated some of its pathogenic properties. He noted that it caused an 
extensive spreading haemorrhagic necrosis when injected subcutaneously 
into rabbits and guinea pigs. Jolly (1965) designed a set of experiments and 
concluded that the exotoxin was important as a permeability factor and that 
the resulting leakage of plasma from small body vessels at the site of 
infection increased the probability of spread of the organism to the regional 
lymph nodes.  
The relative contribution in the pathogenesis made by each of these 
two factors was investigated by Zaki (1976). He found that mice receiving 
viable C.pseudotuberculosis cells developed abscesses throughout the body, 
while mice given the same dose mixed with antitoxin, developed abscesses 
only at the portal of entry. He concluded that the cell wall lipid was the 
pyogenic factor, and that exotoxin was not involved in the formation of 
abscesses, but responsible for the spread of the organism. 
  Kimberling (1988), describing the pathogenesis of CLA, stated that 
after penetration of the organism through broken skin or mucous 
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membrane, the invading bacteria entered the afferent lymphatic then moved 
to the draining lymph nodes where leukocytes accumulated around and 
among the bacteria, then fibroblasts and capillaries were formed at the 
periphery of the site of infection. The toxic bacterial metabolites including 
the exotoxin, slowly killed the leukocytes and tissues. Therefore   the 
typical lesion of the disease consisted of a central mass of necrotic tissue 
surrounded by a wall of connective tissues and capillaries were formed. 
Toxin and ischemia killed the cells of the inner part of the connective tissue 
wall and thus, added a new layer to the necrotic mass. Then new connective 
tissues were formed to reinforce the wall. Successive layers were added to 
the necrotic mass, by repeating this process, thus, the typical lesion of CLA 
was formed. Subsequent spread of  the organism to the lungs and other 
organs via lymphogenous and haematogenous means might have occurred  
in some animals. But spread of the organism from respiratory system to 
other organs occasionally occurred (Maddy, 1953). 
1.1.5. Differences of CLA in sheep and goats: 
The disease primarily affects the large superficial lymph nodes of both 
sheep and goats. The internal form with visceral abscesses is more severe, 
but it is found to be less frequent in both sheep and goats. There are obvious 
differences in CLA between the two species, those are:  
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(i) There is variation in the distribution of lesions. In goats the parotid 
node is affected most commonly, followed by the prescapular and then by 
other nodes, often found in the head and neck area. The superfacial lymph 
nodes in the caudal half of the body are infrequently affected (Ayers, 1977). 
In  comparison the lesions in the head and neck area are relatively rare in 
sheep. The precrural node is the most  likely to be affected, followed in 
frequency by the perscapular  and then by other lymph nodes over all the 
body surface with equal frequency (Ayers, 1977).  
(ii) The morphological appearance of the abscessed node differs in 
sheep from that in goats (Ayers, 1977). In sheep it was found that the 
abscessed node often had a characteristic lamellated appearance with 
concentric fibrous bands separated by inspissated caseous material giving 
onion ring configuration. In goats, abscessed nodes  did not have that shape 
and the exudates are usually uniformly pasty rather than dry. This may be 
due to the more liquefactive nature of phagocytic enzymes of goats (Ashfaq 
and Cambell, 1979). 
(iii) The occurrence of visceral form of CLA was found to be less 
common and less extensive in goats than that encountered in sheep 
(Renshaw et al., 1979); (Hein and Cargill, 1981). There is a greater  
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tendency for multiple internal nodes to be affected in sheep (Hein and 
Cargill, 1981; Musa, 1998).  
1.1.6. Serological diagnosis of CLA: 
Diagnosis of CLA by palpation of external lymph nods does not detect 
carriers, and early cases or animals with visceral form of the disease. Also 
by this method, CLA can be confused with Morel’s disease. Hence, many 
serodiagnostic tests have been investigated, but none of these was adequate 
for widespread use in a programme of eradication by culling diseased or 
carrier animals. However, several tests have been developed for the 
diagnosis of CLA, most of these measure the humoral response to the 
exotoxin (Brown and Olander, 1987). 
1.1.6.1. Skin test: 
  Carne (1939) developed a diagnostic test similar to the Schick test in which 
an amount  of the necrotizing exotoxin was injected intradermally. The 
effect of the toxin was neutralized immediately and there was no reaction in 
animal having antibodies. While in absence of antibodies, spreading 
redness and swelling visible for several days occurred.  Carne injected 
C.pseudotuberculosis intradermally into 100 sheep with CLA, irregular and 
independable reactions were noticed. 
 Doty et al. (1964) attempted a skin test in which exotoxin was titrated with 
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the test  serum and injected intradermally in rabbits. Absence of necrosis 
was an indication of the presence of antibodies. 
   1.1.6.2. Haemolysis inhibition test (HIT): 
   Haemolysis inhibition test (HIT) is a test for detection of antibodies to   
C.pseudotuberculosis exotoxin. The test based on neutralization of 
C.pseudotuberculosis exotoxin by antitoxin. Application of HIT for assay of 
antitoxin response had been described in preliminary reports on vaccination 
against C.pseudotuberculosis (Burrell, 1976, 1978b) and experimental 
infection (Burrell, 1976). Burrell (1980a) used the test for diagnosis, to 
detect antitoxin in 24 out of 30 sheep with proven caseous lymphadenitis on 
autopsy.  
   1.1.6.3. Bacterial agglutination test (BAT): 
Agglutinating antibodies are produced in many infections and 
particularly those in which invasion of the blood stream takes place. 
Agglutinating antibodies could be obviously demonstrated if suitable 
antigen suspensions could be prepared. Shigidi (1979) applied the method 
for diagnosis of C.ovis infection in sheep in a comparative study. Lund et 
al. (1982) utilized the test for detecting CLA among goats. They reported 
that the test was easy and quick to perform. Brogden et al. (1984) used BAT 
for monitoring the serologic response in vaccinated animals.   
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1.1.6.4. Anti-beta haemolysis inhibition test (ABH): 
Utilizing the exotoxin property of inhibition of red blood cell lysis by 
Staphylococcal beta-lysis, Zaki (1968) developed the ABH test. Dilutions of 
a test serum were incubated with a standard amount of exotoxin and bovine 
erythrocytes and then staphylococcal haemolysin was added. In the absence 
of antibodies, C.pseudotuberculosis exotoxin occupied the receptor site on 
the erythrocyte membrane preventing the beta lysin by exerting its 
haemolytic effect. This method had sensitivity and specificity levels of 92% 
and 96%, respectively, as measured by Zaki(1968) in an abattoir survey of 
200 goats and sheep. 
1.1.6.5. The synergistic haemolysis inhibition test (SHI): 
       This test was developed by Knight (1978) for diagnosis of 
C.pseudotuberculosis  infection in horses. It utlized the complementary 
actions of exotoxins for C.pseudotuberculosis and C.equi to cause 
haemolysis synergically. Brown et al. (1986) used the SHI test to detect 
unapparent CLA in sheep and goats. The test was applied to serum samples 
from 196 goats and 76 sheep including animals with and without abscesses. 
Fifty-one out of 52 (98%) goats and 27 out of 28 (96%) sheep with 
abscesses caused by C.pseudotuberculosis had seropositive titers and the 
seropositivity continued on subsequent sampling even after  healing of 
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superficial lesions. It was suggested that the SHI might detect sub- 
clinically infected animals as well as animals with clinical lesions. In 
animals with no abscesses, 53  (28%) of 186 goats and 4 out of 41 sheep 
were seropositive. They concluded that either the SHI was lacking 
specificity or the titres were a reflection of past or current infection without 
any grossly visible abscesses. 
1.1.6.6. Indirect Haemoagglutination test (IHT): 
     Shigidi (1978) described an indirect haemoagglutination (IHT) test for 
diagnosis of CLA in sheep. Purified C pseudotuberculosis toxin was used to 
sensitize formalinized sheep erythrocytes treated with diazobenzidine. His 
results showed that the IHT was a sensitive method for detection of 
C.pseudotuberculosis antibodies. The author evaluated the IHT and the anti-
beta haemolysis inhibition tests for the serodiagnosis of CLA in sheep, 
results indicated that neither of the tests was 100% reliable. 
1.1.6.7. Microagglutination test: 
       Menzies and Mukle (1989) examined two flocks composed of 326 and 
four sheep flocks of 34 animals for the presence of abscesses and antibody 
levels. All those animals previously suffered from CLA. The sensitivity of 
this method was poor to good for both species (52.3% for goats and 89.7%  
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for sheep). The specificity was fair to poor (64.9% for goats and 21.7% for 
sheep).  
 1.1.6.8. Immunodiffusion test (IDT): 
     Burrell (1980b) reported this method for diagnosis of CLA. In this test  
exotoxin and sera, from sheep and goats, were used as reactants in double 
immunodiffusion test. When this method was used for diagnosis, sera from 
32 confirmed cases of CLA in sheep and goats were positive whereas sera 
from 16 sheep free from CLA were negative. 
1.1.6.9. Enzyme – linked – immunosorbant assay (ELISA):   
    Sutherland et al. (1987) used two ELISA tests to measure antibody 
response to cell wall antigens (C-ELISA) and exotoxin antigen (T-ELISA) 
to detect CLA in naturally infected sheep. The sensitivity and specificity of 
C.ELISA was 76% and 73% respectively and for T.ELISA was 67% and 
77% respectively. Kuria and Holstad (1989) correlated between haemolysis 
inhibition test (HIT) and the ELISA. They examined sera from 52 sheep 
using HIT and ELISA, results showed high correlation between the HIT and 
the antitoxin ELISA. Ellis et al. (1990) found that C.ELISA detected 96.9% 
(32/33) of sheep with CLA and T.ELISA detected 84.8% (28/33) in the 
same group of positive sheep. Ter Laak et al. (1992) used double antibody 
sandwich ELISA and immunoblot  analysis to detect antibodies targeted the 
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exotoxins, they tested field sera to evaluate the  assay on a large scale basis. 
The ELISA specificity and sensitivity was about 100%. 
Drecksen et al. (2000) modified a double antibody sandwich ELISA 
(ELISA A) developed for the detection of Corynebacterium 
pseudotuberculosis  to improve its sensitivity. To establish the sensitivity of 
this modified ELISA (ELISA B), sera from 183 sheep and 186 goats were 
tested using ELISAs A and B. Comparison was also made with two further 
ELISAs (C and D) developed in Australia respectively, that detect 
antibodies to cell wall antigens or toxin. ELISA B had the best performance 
of the four tests. Its specificity was 98 ± 1% for the goats and 99 ±1% for 
sheep. Its sensitivity was 94 ± 3% for goats and 79 ± 5% for sheep.     
Kaba et al. (2001) developed an ELISA  for the diagnosis of 
Corynebacterium pseudotuberculosis infections in goats. A bacterial whole 
cell extract was used as solid-phase antigen, and serum from a 
culturepositive animal served as the internal reference standard. The well-
to-well and assay-to-assay variations were determined to be 12.7 and 
33.0%, respectively. A cut off value was determined by parallel testing of 
142 sera (112 ELISA-positive, 30 ELISA-negative) in a Western blot, and 
the correlation between both tests was highly significant (K= 0, 93). In 
addition, the reliability of the ELISA for the detection of infected herds was 
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proven in a double blind study testing 910 sera from 74 goat herds.      
Binns et al. (2007) developed an ELISA using sonicated C 
. pseudotuberculosis and optimised to detect total antibody or IgG class  
 
antibody in serum. Receiver operating characteristic (ROC) curves were  
 
obtained and the area under the ROC curve was used to compare the 
 
 sensitivity and specificity of the two ELISAs. Both versions of the ELISA  
 
were evaluated on a panel of 150 positive reference sera and 103 negative  
 
reference sera. Using the test at 100% specificity, the sensitivity of detection  
 
of total antibody was 71% (95% confidence interval 63–78%), and the 
 
sensitivity of detection of IgG antibody to C. pseudotuberculosis was 83% 
 
 (76–89%), which compares favourably with  other reported ELISA tests for  
 
CLA in sheep. The sensitivity of the IgG antibody assay may be higher  
 
because of the greater affinity of IgG class antibodies compared with the  
 
IgM  antibodies also detected by the total antibody ELISA. The results of  
 
ROC analysis indicated that the IgG isotype ELISA was more accurate than  
 
the total antibody ELISA. The efficiency of the test was greatest when serum 
 
 samples were run in a dilution series than when any single serum dilution  
 
was used. 
1.1.6.10. Blood interferon-gamma assay: 
Sunil et al. (2008) validated a whole blood interferon-gamma (IFN-g) 
 enzyme immunoassay (EIA) (Bovigam, Pfizer) in experimentally infected  
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sheep and in a flock of known-negative sheep, as well as in a naturally  
infected flock, a proportion of which was vaccinated with a commercial  
CLA vaccine. An optical density (OD) at (540 nm) and a cut-off of 0.09 was 
 effective in classifying animals as test positive or negative in the naturally  
infected flock, although there was variation in OD between visits, notably  
with weakly reacting animals. The test had a sensitivity of 91% and a  
specificity of  98%. Postmortem data supported the results in test-negative  
animals. Visit-to-visit variation in IFN-g EIA OD in the naturally infected  
flock as well as CLA disease status was used to develop an algorithm for the  
eradication of CLA from a known infected flock. The whole blood IFN-g  
assay shows promise for eradication of caseous lymphadenitis from sheep  
flocks. 
1.1.7. Immunization against caseous lymphadenitis:  
A  protective immunity for sheep to control caseous lymphadenitis was first 
described by Quevedso et al. (1957). Trials in Patagonia and Argentina 
using formalized culture of C.pseudotuberculosis with aluminum hydroxide 
adjuvant to vaccinate sheep achieved a reduction in infection to up 60%. 
Jolly (1965) injected varying numbers of C.pseudotuberculosis into mice. 
High concentrations caused an acute illness  and death within three to four 
days due to systemic effect of the exotoxin. Small numbers of the organism 
caused a subacute illness, and the animals developed abscesses in internal 
organs. He noticed that recovery from infection was greatly associated with 
the presence of mature and specialised macrophages in the lesions. He 
 37 
assumed a cellular type of immunity associated with the onset of acquired 
resistance. 
      Cameron et al. (1969) immunized mice with formalinized 
corynebacterial suspension, cell wall and protoplasm and evaluated their 
immunogenicity by intravenous challenge. The cell wall preparation was a 
good immunizing agent. He concluded that the protective antigen was a cell 
wall protein. 
       Later workers have stressed the importance of cell-mediated rather than 
humoral immunity in preventing the formation of abscesses. Hard (1970) 
demonstrated the role of cell-mediated immunity in an adoptive transfer 
experiment. Cameron et al. (1972) inoculated merino sheep with formalin- 
inactivated suspension of C.pseudotuberculosis culture. Vaccination 
protected against acute or subacute death, but did not prevent development 
of abscesses. lrwin and Knight (1975) also provided evidence of importance 
of cell-mediated immunity. Mice given levamisole and 
C.pseudotuberculosis bacterin  were significantly able to resist challenge 
with virulent C.pseudotuberculosis  compared to those which received 
bacterin alone. Levamisole enhances the differentiation of T lymphocytes 
and their response to antigens. The enhanced resistance was found to be 
associated with quantitative reduction in serum immunoglobulin levels. 
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Zaki (1976) demonstrated the role of the two arms of immune response and 
concluded that antitoxin did not interfere with multiplication of the 
organism but hindered its systemic spread, whereas the cell-mediated 
immunity restricted bacterial proliferation. 
       Nairn et al. (1977) vaccinated 24 weaner sheep with formalinized 
concentrated crude exotoxin, then challenged vaccinated and control 
animals. All vaccinated and control animals developed suppurative lesions 
at the site of challenge. Two control animals died with severe haemolytic 
anaemia within 24 hour after challenge. Surviving controls had multiple 
abscesses. Out of the 24 vaccinated animals only three had lesions which 
were single; two of these lesions were sterile for bacteria. The authors 
concluded that an immune response to the exotoxin played a significant role 
in resistance. Similar results were obtained by Burrell (1978b) who found 
that sheep receiving toxoid with adjuvant or toxoid plus formalin 
inactivated cells incorporated in adjuvant had better protection than animals 
which received washed formalin inactivated cells with adjuvant. 
     Anderson and Nairn (1982) Vaccinated goats with a toxoid and 
challenged them by abraded skin method. Three months after challenge, 
 only three out of 20 vaccinated compared to 10 out of 10 controls had 
abscesses at slaughter.  
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       Brogden, et al. (1984) examined whole cells and cell wall for their 
immunizing properties in lambs. They found that there were significantly 
fewer abscesses and fewer organisms in vaccinated animals. The lambs 
inoculated with the cell wall preparation had fewer lesions compared to 
these inoculated with whole cells. 
        Brown et al. (1986) vaccinated 10 lambs with a toxoid mixed with 
Freund’s incomplete adjuvant and challenged them by intradermal 
inoculation. Thirteen weeks later, 8 out of 10 vaccinated lambs were free of 
disseminated lesions at post mortem compared to four out of five controls, 
which showed disseminated lesions. 
       Lea Master et al. (1987) evaluated the efficacy of C.pseudotuberculosis 
vaccine to protect sheep from CLA in controlled challenge exposure 
experiment. Lambs were vaccinated subcutaneously in the right axillary 
region with a bacterin. Twenty weeks later, they were challenged 
subcutaneously at four different sites with 6X10
6
 CFU of 
C.pseudotuberculosis and at week 33 post vaccination, the animals were 
killed and necropsied. The number of abscesses in each lamb was counted. 
Results indicated that the vaccine provided immunological protection of 
lambs against challenge exposure to C.pseudotuberculosis.  Holstad, Teige 
and Larsen (1989) used crude filtrated C.pseudotuberculosis toxoid and 
 40 
whole killed organisms, levamisole was included as immunostimulant. Four 
weeks later, animals were challenged subcutaneously with live bacteria. 
Abscesses were significantly more common in unvaccinated animals at post 
mortem two months after challenge. However, all groups developed 
abscesses at the inoculation site. Brogden et al. (1990) investigated the 
effect of muramyl dipeptide (MDP) on the immunogenicity of 
C.pseudotuberculosis whole cell vaccine in mice and lambs. Efficacy of 
vaccination was determined from the survival of mice and appearance of 
lesions in lambs after intravenous injection of 10
4
 CFU  of 
C.pseudotuberculosis. In mice, protection was related to the concentration 
of whole cells (W.C) in the vaccines. At 50 μg, 100 μg, or 150 μg of W.C, 
protection was good (78.8%). At 10 μg or 25 μg of W.C, protection was 
considerably less (54.7%). At low W.C. concentration, protection 
significantly decreased to 32%.  Eggleton et al. (1991a) vaccinated groups 
of sheep with vaccines of C.pseudotuberculosis toxoid combined in varying 
amounts with five clostridial antigens. These groups were infected at1, 6 
and 12 months after vaccination with pus from ovine lymph nodes which 
showed infection with C.pseudotuberculosis. Three months after challenge, 
resistance was assessed by slaughter and inspection of the sheep for CLA 
lesions. They found a significant reduction of lesions in the immunized 
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sheep compared with control ones. Also they found a positive correlation 
between amount of C.pseudotuberculosis  toxoid administered and degree 
of protection obtained. Eggleton et al. (1991b) immunized sheep with 
C.pseudotuberculosis vaccines prepared from toxoid solely or from toxoid 
with addition of formalin-killed cells of C.pseudotuberculosis. Sheep were 
challenged 6 months after vaccination with caseous lymphadenitis pus 
through skin incisions. Resistance was assessed three months later by 
slaughter and inspection of sheep for lesions of CLA. Immunized sheep 
were protected and there was reduction in the number of sheep exhibiting 
CLA lesions compared to control animals. Some of theses animals were 
free of lesions; few showed lesions which were smaller in size and lesser in 
number compared to control non-vaccinated sheep. They found that there 
was no improvement in protection by inclusion of whole cells of 
C.pseudotuberculosis. Simon- Valenica et al. (1992) prepared three 
vaccines from defatted whole cells of C.pseudotuberculosis with different 
adjuvants: trehalose 6-6 diester (Vaccine A) dextran sulfate (Vaccine B) and 
Al (OH)3 with saponin (Vaccine C). The fourth vaccine was a toxoid 
prepared from C.pseudotuberculosis exotoxin in  water-in-oil emulsion. 
Four groups of 10 four-week-old mice were given two subcutaueous 
injections of one of the vaccines at four-week interval, then challenged 
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interavenously 2 weeks later with virulent C.pseudotuberculosis. The best 
but not complete protection was given by vaccine B. 
  Uysal et al. (1993) tried BCG in inducing immunity for lambs against 
C.pseudotuberculosis. Thirty healthy one-month old lambs with negative  
intra-dermally (i/d) tuberculin test were used. Twenty were injected i/d with 
0.1 ml BCG vaccine. Tuberclin tests, 1and 2 months after vaccination 
showed increased skin reactions (skins thickness increased 2-5 times), tube 
agglutination tests with cornynebacterium antigen were also positive two 
months after BCG vaccination. The vaccinated and control sheep were then 
challenged by i/d injection using C.pseudotuberculosis in the prescapular 
region. Of the 10 controls; two died in one week, while abscesses 
developed at the injection site, the vaccinated animales remained healthy. 
Alive sheep gave positive tube agglutination tests after challenge. Pepin et 
al. (1993) determined the efficacy of acquired immunity in controlling CLA 
and the effect of primary infection on subsequent exposure. Adult 
seronegative ewes were inoculated with streptomycin-resistant  strain  19R 
C.pseudotuberculosis in the right ear. This protocol indicated that the 
primary infection with at least 10
7
 viable bacteria, induced strong protection 
against subsequent challenge exposure whereas immune-naïve ewes 
developed numerous pyogranulomas in the right ear, in lymph nodes 
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draining the inoculation site, and in the lungs. However, ewes with primary 
infection remained carriers of the organism as a result of primary 
inoculation. 
A ribosomal preparation of C.pseudotuberculosis for immunization 
against CLA in Sudan has been examined (Suleiman, 1995). The ribosomal 
preparation was diluted to an appropriate concentrations with phosphate 
buffer, filter sterilized, and inoculated s/c into 8 week old male and female 
Swiss mice with or without Freund’s incomplete adjuvants (1:1) Saponin at 
an amount of 20μg/mouse was also used as an immunostimulant. Control 
groups without immunization which were inoculated with adjuvants alone 
were included. All mice were challenged s/c with 2.4 X10
2 
CFU 
C.pseudotuberculosis 10 days after initial inoculation. Their results showed 
that at low concentration of single dose of 100μl ribosomal preparation, 
saponin did not enhance any protection, whereas with Freund’s incomplete 
adjuvant (FIA) there was 25% protection. When animals were immunized 
with 200μl dose administered with FIA and saponin, protection was 75% 
and 80% respectively compared to 30% when the same dose was 
administered without an adjuvant, and  controls showed no protection. Mice 
which received one dose of 200 μl showed 70% and 60% protection for the 
ribosomal preparation administered with saponin and FIA, respectively, 
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whereas mice receiving an initial immunization dose (200 μl) followed by a 
booster of an equal amount, after one week showed 100% and 60% 
protection for the preparation with saponin and FIA, respectively. All 
control mice showed no protection. Animals immunized with ribosomes in 
saponin showed 100% protection when challenged via the s/c and i/v 
routes, while those receiving the preparation in FIA showed 60% and 50% 
protection for the s/c and i/v routes, respectively. They stated that the 
ribosomal preparation from C.pseudotuberculosis protected immunized 
mice against challenge by the same organism. The degree of protection 
depended on the dose. The highest levels were obtained when 1-2 weeks 
immunization schedules was followed and it was significantly enhanced by 
incorporation in adjuvants. They found that protection was better when 
saponin was used in comparison to Ferund’s incomplete adjuvant. 
In a field investigation, Stanford et al. (1998) found 50-94% of sheep 
had antibodies to C.pseudotuberculosis prior to initial vaccination. To 
assess the efficacy and impact of vaccination with two commercial 
(Glanvac-6 and Case- Vac) and one experimental whole cell vaccine 
containing the synthetic adjuvant muramyl dipeptide -sn- glyceryl- 
dipalmitoyl  (WC+MDP-GDP) CLA vaccines, a series of three field trials in 
3241 ewes and lambs were conducted in affected flocks from 1992-1996. 
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Overall, agglutinating antibody titers to C.pseudotuberculosis in lambs 
vaccinated with WC+MDP-GDP and Case-Vac,   remained significantly 
elevated above unvaccinated control lambs for 12 months after the 
vaccination. Lambs vaccinated with the WC+MDP-GDP maintained higher 
titres than those vaccinated with Case-Vac for 6-12 months after 
vaccination. Agglutinating antibody titres form lambs vaccinated with 
Glanvac did not differ from those of controls for months after vaccination. 
The number of injection site reactions was elevated in lambs vaccinated 
with Glanvac compared with those vaccinated with WC+MDP-GDP, but 
size of infection site reactions did not significantly differ. Sheep vaccinated 
with WC+MDP-GDP also had a reduced incidence of CLA abscesses, 
although confirmation of the presence of C.pseudotuberculosis was only 
successful in 5 cases.  
Hodgson et al. (1999) evaluated the efficacy of CLA vaccine 
formulated using genetically inactivated PLD in sheep. The vaccine 
protected 44% of sheep against C. pseudotuberculosis challenge compared 
with 95% protection offered by the formalin inactivated preparation. 
Chaplin et al. (1999) performed a large- scale vaccination trial in sheep 
to investigate   whether an antigen targeted by CTLA-4 enhanced and 
accelerated the humoral immune response. Vaccination with genetically 
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detoxified phospholipase D has been shown to be effective, at least 
partially, against C. pseudotuberculosis infection. CTLA-4 bind to B7 on 
antigen- presenting cells and thus was used to direct the fusion antigens to 
site of immune induction. They demonstrated that targeting phospholipase 
D as a CLTA-4 fusion protein significantly enhanced the speed, magnitude 
and longevity of the antibody response compared to that obtained with 
DNA encoding phospholipase D. While all groups of sheep vaccinated with 
DNA encoding phospholipase D were afforded better protection against an 
experimental challenge with C. pseudotuberculosis than those immunized 
with an irrelevant plasmid or those left unimmunized, the best protection 
was provided by the targeted DNA vaccine.  
              Abdel Wahab (2000) in an immunization study prepared two vaccines, 
cell wall (C.W) lysate and C.W lysate + toxoid. The two vaccines were 
incorporated in saponin. Three doses of each vaccine with one-month 
interval were injected s/c into two groups of goats of five animals in each. 
The third group was left as unvaccinated control. Three weeks after the last 
vaccine dose all animals were challenged i/v by 1.2Χ105  CFU/ml of 
C.pseudotuberculosis C P 41N. Then one month after challenge all animals 
were slaughtered and examined for CLA lesions. 
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       There was significant reduction (P<0.01) in lesions in animals vaccinated 
with C.W lysate and C.W lysate + toxoid compared with the controls. On the 
other hand there was significant reduction (P<0.05) in the number of lesions 
in animals vaccinated with C.W lysate +toxoid compared with animals 
vaccinated with C.W lysate alone. After challenge, two animals (40%) died 
from both C.W lysate vaccinated group and the control group. Whereas there 
was no death among animals vaccinated with C.W lysate +toxoid. In this 
latter group there were only two animals with lesions (40%), whereas in the 
C.W lysate vaccinated and control animals lesions were found in all animals 
(100%). The percentage of lesions in internal organs (lungs, livers, spleens, 
kidneys, pericardia, omenta, mediastinal and mesenteric lymph nodes) was 
20%, 30%, and 57.5% for C.W lysate + toxoid, C.W lysate vaccinated 
animals and controls, respectively. 
         Fontaine et al. (2006) using a virulent isolates of C.pseudotuberculosis 
from United Kingdom (UK) , an ovine experimental model of CLA was 
developed, in which the manifestation of disease was equivalent to the 
naturally observed infections in UK. Subsequently, the capacity of several 
experimental vaccines to protect against experimental challenge was 
determined. Sheep were immunised with a recombinant derivative of 
phospholipase D, derived from the virulent UK isolate, a formalin-killed 
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bacterin of the same strain, or a bacterin supplemented with recombinant 
phospholipase D. Following homologous experimental challenge, the 
phospholipase D and bacterin vaccines were observed to confer statistically 
significant protection against infection, and appeared to restrict 
dissemination of challenge bacteria beyond the inoculation site in the 
majority of animals. More importantly, the combined vaccine succeeded in 
providing absolute protection against infection, whereby challenge bacteria 
were eradicated from all vaccinates. In addition to the experimental 
vaccines, a commercially available CLA vaccine, unlicensed for use in the 
European Union, was assessed for its capacity to protect against 
heterologous challenge. The vaccine conferred significant protection, 
although the dissemination of infection beyond the inoculation site was not 
restricted as it had been with the previous vaccines. However, no animals 
immunised with this vaccine manifested infection within the lungs; thus, a 
potentially important route of disease transmission was eliminated.  
Braga (2007) evaluated  the immune potential of different doses of cell wall  
 
and toxin components of C. pseudotuberculosis from alpaca origin, 12 adult  
 
alpacas were allotted at random to four groups, and were s/c inoculated 
 
in the left flank with vaccines composed of low and high doses of bacterial  
 
crude antigens, cell wall: 250 and 500 mg/ml and toxin:133 and 265 mg/ml,  
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respectively. The vaccines were supplemented with 20 mg/ml of muramyl  
 
dipeptide as adjuvant. Three alpacas were inoculated with adjuvant alone as  
 
a control. After three weeks, immunized and naive alpacas were challenged  
 
intradermally in the right flank with 1 X 10
6
 colony forming units (CFU) of  
 
C. pseudotuberculosis. The alpacas were sacrificed at days 28, 58 and 112 
 
after inoculation, and the degree of protection induced by vaccines was  
 
demonstrated by the absence of abscesses and/or bacteria. The alpacas  
 
vaccinated with high doses of the toxin, did not show abscesses. In contrast, 
 
 the  alpacas vaccinated with a low dose of toxin showed abscesses  
 
at the inoculation site, regional, and renal lymph nodes. The alpacas  
 
vaccinated with  cell wall showed a lesser degree of protection than the other  
 
groups with superficial and internal abscesses. The control alpacas had  
 
persistent fever and abscesses at the inoculation site, regional, and internal  
 
lymph nodes. In addition, a robust and early humoral response was observed  
 
in all vaccinated alpacas after challenge, lasting at least three months.  
 
         In a study Moura-Costa et al. (2008) used four different antigenic 
extracts obtained from the attenuated strain T1, which was isolated in the 
state of Bahia (Brazil). Forty-four Canindé breed goats were divided in five 
groups, each received a different antigen solution and saline buffer only for 
the control group. The humoral response was monitored through the 
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identification of specific IgG by indirect ELISA and Western Blotting, and 
the production of IFN-γ was followed in order to observe the activation of 
cellular response. After 12 weeks of antigen inoculation, the animals were 
challenged with 2 × 10
5 
 CFU of a wild strain of C. pseudotuberculosis, also 
isolated in Bahia, and necropsy was performed on all animals 12 weeks 
afterwards. It was observed that the attenuated bacteria gave a protection of 
33.3%, and a humoral response was elicited. Animals inoculated with 
antigen associated with Freund's incomplete adjuvant and 
oligodeoxynucleotide containing unmethylated CpG dinucleotides (CpG 
ODN) showed a strong humoral response, but this inoculation could not 
prevent the spread of challenge bacteria in the majority of animals.  
1.2.Methods of cultivation of C. pseudotuberculosis for mass production:   
    Different methods for mass cultivation were tried using solid agar and 
liquid media either in a batch or continuous culture . The variability of the 
strains and the amount of the CFU per dose were considered as the most 
critical factor in determination of a vaccine efficacy  
The theory of continuous bacterial cultivation in liquid media was first 
discussed by Monod (1942) and Novick and Szilard (1950). Based on that, 
microbial growth in a continuous culture occurs at a constant rate and at 
constant environment. factors such as a pH value, concentration of 
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nutrients, metabolic products and oxygen are constant. Some of the early 
workers (Golle, 1953; Fin and Wilson, 1954) disagreed with the concepts 
drawn by Monod (1942) and Novick and Szilard (1950), but many others 
considered the concepts had constructed the basis of a correct theoretical 
treatment for bacterial cultivation in static and continuous systems (Herbert 
et al., 1956)  
1.2.1. Batch culture:                                                                                                     
    Batch culture is the growth of bacteria in a system where no fresh 
nutrients are added, nor the metabolic  products are removed during the 
process of growth, which causes progressive changes in the medium 
component that no further growth could be supported. The characteristic 
sequence  of changes are referred to as the "growth cycle" (Monod, 1949; 
Pirt, 1975). 
When environment remain favorable, growth will continue until one of the 
essential substrates in the medium is depleted, and it is called the growth 
limiting substrate if all other nutrients are in excess.  
The specific growth rate (the rate of increase / unit) of microorganisms is 
dependant on the concentration of the growth limiting substrate according 
to the empirical equation of Monod (1942, 1949): 
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µ = µ max  (S         ) 
                    ks + S                                
Where µ is the specific growth rate, µ max is the maximum specific growth 
rate, S is the concentration of the growth limiting substrate and ks is a 
constant, numerically equal to the substrate concentration at which 
 µ = ½ µ max  
Monod (1942) also demonstrated the relationship between growth rate (d x) 
and the substrate utilization (d s) in the following equation:  
d x : weight of bacteria formed                  =      y 
d s  : weight of substrate consumed     
 
Where y: is the growth yield constant  
If the three growth constants µ max, ks and y are known, the above two 
equations will provide a complete description of the growth cycle in a batch 
culture (Monod, 1942). 
1.2.2. Continuous cultures: 
Continuous culture, consists of a culture vessel to which fresh nutrient 
medium is constantly supplied, instantly mixed with the culture thus 
ensuring good homogeneity .The volume of culture in maintained constant 
by an overflow system .Factors such as pH value, concentration of 
nutrients, metabolic products and oxygen, which inevitably change during 
the growth cycle of a batch culture, are maintained constant in a continuous 
 53 
culture. Initially all continuous systems start as    batch culture and the 
continuous flow of fresh medium will provide the culture with additional 
growth limiting substrate, allowing the growth rate of the organism to be    
controlled by the rate of addition fresh medium. The organism is 
simultaneously harvested from the vessel by the over flow device, and  the 
population will be maintained by multiplication provided that the rate at 
which the culture is diluted by addition of fresh medium does not exceed a 
certain critical value. 
           The most commonly used continuous culture system is the flow - 
controlled  device , usually referred to as the chemostat ( Herbert et al., 
1956). In this system the volume of  the medium is V, the dilution rate D of 
the culture is D = F/V ,where F is the flow rate (volume of the fresh 
medium added to the culture vessel / unit time) and the bacterial growth 
follows an experimental pattern , and the growth rate is expressed by the 
formula:  
  dx       =   µx  
  dt   
 
Where x is the cell mass (g/l), µ is the specific growth rate and t is the time. 
The change in the concentration of bacteria in the culture is: 
Change = growth – out put 
Since growth is µx and out put is Dx then: 
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dx  = µx –Dx     or     dx    =     x(µ - D) 
dt                                dt                         
               
The culture will be in steady state wherever µ is equivalent to D, (i. e) the 
bacterial mass added to the system equals to that removed from it. There 
will be no change in status and the bacterial concentration of the organism 
will remain constant with time. When µ > D,  dx/dt is positive and the 
concentration of the organism will increase, when D > µ, dx/dt is negative,  
and the concentration of the bacteria will decrease and the culture will be 
washed out( Herbert et al., 1956). Figure 1 shows the variation of steady-
state concentration, the mean generation time of bacteria and the substrate 
in continuous culture with dilution rate variation.    
1.2.2.1. Types of continuous culture: 
     
According to the operating principles two types of culture apparatus are 
described: 
1.2.2.1.1. Turbidostat:   
The operating principle in this type is the maintenance of a constant 
microbial density (constant culture absorbance). In this case the biomass 
density is first fixed and the dilution rate regulates itself to the required 
biomass level. It was found that turbidostat continuous culture is very 
difficult to stabilize (Bryson, 1952). 
1.2.2.1.2. Chemostat: 
The organism in this type, can be cultured  continuously at a specific 
growth rate less than µmax ( Novick and Szilard ,1950). The culture is 
maintained at a fixed volume to which the medium is pumped at a 
constant rate and the culture is removed from the chemostat at an equal 
rate.  
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Fig. 1: Steady-state relationship in continuous culture (Herbert et al.,1956). 
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1.2.2.1.3. Application: 
 
 According to Golle (1953) and Herbert et al. (1956), the advantages of 
continuous cultivation technique of microorganisms to batch culture are: 
- Increase of production, continuous culture may usually be expected 
according to Golle (1953) and Herbert et al. (1956) to show a five to ten 
fold increase in out put as compared with a batch culture.  
- The system is more adaptable to automation. 
- A uniform product is obtained. 
- Steady load on the utility source is possible with no peak loads.  
- More economic to industrial microbiology. 
- Valuable research tool  
Difficulty in maintaining sterility during long runs that is frequently 
raised against the continuous system. When assembling the different 
parts of the fermenter  and by applying strict sterile measures 
contamination could be controlled and runs of several months are now 
routine in IBT bioreactor (Bőhnel, 1986; Roth, 1986; Babiker, 1991). 
Mutation, is another difficulty of continuous culture but is a rare event 
arising singly, and a single organism with a generation time T has a 
probability of I –еDt of being washed out of the culture vessel before it 
divides once. At this time a considerable number of mutants arising in a 
continuous culture will be removed before they have progeny, while in 
batch culture all will remain (Herbert et al., 1956). Bőhnel (1986) 
described the continuous cultivation of bacteria as state of long-term 
repeated division of bacterial cells, which leads ultimately to selection  
rather  than to mutation .      
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1.2.3. Methods of concentration of bacteria: 
Different methods like filtration, centrifugation precipitation and foam 
separation have been used for antigen purification or concentration and 
separation of the organisms from cultures, the most practical one is 
filtration. 
1.2.3.1. Filtration: 
Filtration as a mean of bacterial harvesting and concentration has found 
its application in improvement of vaccine production. It is considered as 
the least laborious, fast and most economical method for concentration. 
1.2.3.1.1. Cross flow filtration: 
Cross flow filtration is used to produce pure liquids, for concentration of 
suspensions, and recovery of valuable process liquid (Hood, 1990). 
Cross flow filtration either simultaneously, during the fermentation 
processes, or alternatively as down stream processing at the end of 
fermentation (Grabosch, 1987). Tangential cross flow filtration is a 
pressure driven membrane moderated filtration process in which the 
particles to be separated flow parallel to the membrane surface in a 
tangential direction (Hood, 1990; Grabosch, 1987). The solvent with a 
small filterable particles pass through the filter due to pressure gradient, 
which leads to the concentration of non-filterable material in flowing 
solution (Strohmaier, 1967). The rapid strong and continuous flow of the 
suspension to be filtered in across flow filtration system, reduce 
significantly the building of secondary membrane, however it will not 
prevent its formation completely (Michales, 1968; Strathmann, 1981; 
Rähse, 1985). Hence, this filtration technique is superior to the other 
types (Alouf and Raynoud, 1970; Gram and Lai, 1971). Tangential 
filteration , especially the cross flow technique in hollow fibers is mostly 
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done in recirculation systems , which employ pumps as driving forces 
(Gangeni et al., 1977; Klein,1981) . 
1.2.3.2. Types and structures of filters:  
    Strathmann (1981) and Bőhnel (1986) described a variety of synthetic 
filters, which differ in their membrane structure, material and application. 
The basic required qualities of any filter are the thermal, chemical and 
biological stability together with the other necessary physical characteristics 
(Browne, 1942; Michales, 1968; Shiele and Alt, 1978). 
1.2.3.2.1. Membrane filters: 
     Membrane filters are integral structures made of thin highly purified 
porous sheets of different materials; their properties depend on the 
manufacturers. Different uniform pore size filters ranging between 0.22-5.0 
μm in diameter of inert cellulose esters used for both air (Timothy and 
Raymond, 1984) and liquids filtration with high flow rates are available 
(Guadfrin and Sabatier, 1978). 
1.2.3.2.2. Hollow fiber filters: 
       Hollow fiber filters are made of very tightly and parallely arranged 
hollow fibers having a diameter of 0.2 - 1.1 mm (Saier, 1977) and are 
supported with a metal, plastic or glass framework. Different hollow fibers 
of different permeabilites are used for the separation of toxins and 
substances of low molecular weight.      
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Chapter Two 
Materials and Methods 
 
 
2.1. Field survey: 
Two different categories of sheep were surveyed for CLA, the first one is live 
ones at animal markets, and the second is the carcasses of slaughtered animals 
during meat inspection.  
2.1.1. Examination of live animals: 
     A total of 6560 sheep and 4450 goats were examined clinically for the 
presence of superficial abscesses at the local animal markets in and around 
Nyala town, South Darfur state, Western Sudan during the period from 
February 2004 to May 2005. Animals were brought to those markets from 
different parts of the state, and thus representing the animals in the state. A 
total of 54(0.82%) and 34(0.76%) samples of lymph nodes or abscesses were 
collected from sheep and goats, respectively.  
2.1.2. Examination of slaughtered animals at meat inspection: 
 A total of 3324 sheep and 184 goats were inspected at post-mortem 
examination for presence of abscesses at Nyala slaughterhouse. Eighty nine 
(2.8%) and 6(3.3%) affected lymph nodes or abscesses were collected from 
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sheep and goats, respectively. 
2.1.3. Sample collection: 
Live animals were examined carefully for enlarged superficial lymph nodes. 
The outer surrounding skin of these lymph nodes was shaved and disinfected 
with alcohol. Pus was aspirated using sterile needles and syringes.  
Lymph nodes were collected from animals slaughtered at Nyala 
slaughterhouse during the meat inspection, subcutaneous abscesses or 
enlarged lymph nodes samples were removed carefully from the carcass and 
put separately in sterile plastic bags, labeled and taken immediately in a 
thermos flask containing ice  to the Laboratory for culturing. 
2.1.4. Staining methods: 
2.1.4.1. Preparation of smear: 
Direct smears were prepared from puss samples, liquid cultures or emulsified 
colonies on clean dry glass slides. The smears were allowed to dry in air and then 
fixed by gentle flaming and stained with the Gram stain. 
 
 
 
 61 
2.1.5. Culture samples and identification of isolates: 
2.1.5.1. Culture Media: 
2.1.5.1.1. Solid media: 
- Blood agar base No. 2 (Oxoid CM55):  
- Brain heart infusion agar (Oxoid CM375) 
- Nutrient agar (Oxoid CM3, R2) 
- Urea agar base (Oxoid CM53, R3) 
- Serum agar slant 
- Dorset egg medium (Oxoid PM5) 
2.1.5.1.2. Liquid media: 
- Nutrient broth (Oxoid CM1, R1) 
- Brain heart infusion broth (Oxoid CM225) 
- Robertson’s cooked meat medium (Cowan, 1974) 
- Nitrate broth (Cowan, 1993) 
- Peptone water sugars (Cowan, 1993) 
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2.1.5.2. Reagents: 
- Hydrogen peroxide 
- Nitrate test reagents 
2.1.5.3. Solutions: 
- Normal saline (0.85%): 
- Phosphate buffered saline solution (PBSS) 
2.1.6. Biochemical methods: 
2.1.6.1. Catalase test: 
A drop of 3% aqueous solution of hydrogen peroxide was put on a clean 
microscope slide. A colony of test culture, on nutrient agar, was placed on the 
hydrogen peroxide drop. The test was considered positive if gas bubbles 
evolved on the surface of the culture material. 
2.1.6.2. Urease activity: 
Urease activity was shown by alkali production (ammonia) from urea split by 
the test organism. Heavy inoculums was transferred to the urea agar slope and 
incubated at 37℃ and examined daily. A positive test was indicated by pink or 
red colour; negative results were not considered before the end of 7 days.  
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        2.1.6.3. Nitrate reduction: 
To test the ability of the organism to reduce nitrate to nitrite, the test culture 
was inoculated in nitrate broth, and incubated at 37℃ for two days.  One ml of 
solution A (sulphanilic acid) was added to the test culture followed by 1 ml of 
solution B (α- naphtylamine). A positive reaction was indicated by 
development of red colour. If the result was negative zinc dust was added. A 
red colour indicated the presence of nitrate which was reduced by zinc to 
nitrite. 
2.1.6.4. Carbohydrates fermentation: 
Peptone water and nutrient broth sugars were inoculated with the organism 
under test and examined daily for seven days for acid production. 
2.1.7. Blood and serum collection: 
Blood and serum used to enrich media were collected by veni-puncture of the 
jugular vein of a healthy sheep. Blood was collected in sterile containers, 
defibrinated with sterile glass beads (1.5-2 mm. in diameter) and used for 
preparation of blood agar and sheep erythrocytes suspension for haemolysis 
tests. Blood needed for serum preparation was allowed to clot at a room 
temperature for one hour. By using a sterile glass rod the clot was separated 
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from the walls of the containers, which were then transferred to a refrigerator 
at 4℃ and left overnight. Serum was pipetted into  tubes and centrifuged at 
3000,  r.p.m for 10 minutes and the clear straw-cloured fluid was dispensed in 
10 ml amounts, inactivated in water-bath at 56 ℃ for 10 minutes then stored 
frozen at –20℃   until needed. The serum was used for serological tests was 
collected from vaccinated or control animals 
2.1.8.  Sterilisation: 
Glassware such as petri-dishes, tubes, flasks, graduated pipettes and glass 
beads were sterilised in a hot air oven at 160℃ for 90 minutes. 
Capped bottles, swabs, solutions and all media except sugars were sterilised at 
110℃ for 5 min. Cotton stoppered tubes were wrapped in yellow paper, and 
sterilized in the autoclave at 121℃ (15 lb/ square inch) for 15 minutes. 
2.1.9. Isolation of C. pseudotuberculosis: 
When abscesses or lymph nodes were brought to the laboratory, they were cut 
open by means of sterile scalpels after searing the surface with hot spatulas. 
From the periphery of the lesions, a loopful of pus was streaked onto blood 
agar plates. The plates were incubated microerophilically, in a desiccator, 
under 10% Co2 tension at 37 ℃  for 48 hours.   
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2.1.10. Identification of isolates: 
From a single colony on blood agar, a thin smear was made on a clean glass 
slide. This was air dried, fixed by heat, stained by the Gram’s method and 
examined under the oil immersion lens for the characteristic short coccobacilli. 
The isolates were tested for catalase and urease activity and nitrate reduction. 
Purification was accomplished by subsequent subcultures on blood agar plates to 
obtain pure cultures.  
2.1.11. Preservation of isolates: 
To preserve  isolates of C.pseudotuberculosis, were inoculated in serum agar 
slants, Dorset egg slants and cooked meat medium, and incubated for 24 hours at 
37℃, then after check for purity, were  stored at –40℃ 
2.2. Mass Cultivation of C. pseudotuberculosis using IBT Bioreactor: 
2.2.1. Bioreactor setting up and assembling: 
The system is constructed and developed to cope with the conditions in the tropical 
countries. The bioreactor was used successfully for production of bacterial 
vaccines (Roth, 1986; Hἃusser, 1989; Babbiker, 1991; Schaper, 1991; Elbashir, 
1993; Sonnenberg, 1993;  Rengel, 1993;  Suleiman, 2001; Mona El haj, 2002). In 
addition to some vaccines against some viral diseases (NiBlein, 1993; Ullrich, 
1994).  
         The IBT bioreactor is a closed system for medium sterilization, bacterial 
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culturing and harvesting. The  internal positive pressure  made by a circulation  
pump plays  the main role  in protection of the  system against contamination 
(Figure 2).  
        The bioreactor consisted of the following functional parts: 
- Bioreactor control circuit. 
- Fermenter tank. 
- Aeration system. 
- Medium sterilization and supply 
- Air filters. 
- Sampling system. 
- Harvest and inactivation unit. 
         The other basic, replaceable and autoclavable materials of the IBT bioreactor 
were: 
- Silicone tubes and stoppers of different sizes 
- Glassware.  
- Stainless steel tubes of different sizes. 
- Stainless steel male and female connectors (Swagelock). 
- Polypropylene connectors (T and Y shapes). 
- PTFE ring septa coated magnetic rods, silicone ring septa.   
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Fig. 2: IBT bioreactor set-up for production of C. pseudotuberculosis 
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2.2.2. Propagation of C.pseudotuberculosis: 
2.2.2.1. Bacteria: 
A local strain of C.pseudotuberculosis strain CP 41N isolated from sheep was used 
as a seed for inoculation in bioreactor. This strain was selected because of its high 
growth yield and increased haemolytic titre (Abdel Wahab, 2000). 
2.2.2.2. Preparation of seed and inoculum: 
Lyophilized C.pseudotuberculosis strain Cp41N was reconstituted in nutrient 
broth, incubated at 37 º C for 24 hours then injected I/M into a rabbit. The rabbit 
died after 12-18 hours, samples from liver and site of injection were cultured onto 
blood agar, after 24 hours of incubation at 37 º C, from the colonies of C. 
pseudotuberculosis that appeared one colony was taken into brain heart infusion 
broth with 0.1% Tween 80 (BHIB+T). One milliliter of the broth was inoculated 
into 50 ml of BHIB+T, incubated at 37 º C for 24 hours. Growth could be detected 
by turbidity. Smears were made from the broth, stained by Gram's stain to check 
purity. This inoculum was used for inoculation the fermenter.  
2.2.2.3. Media used: 
Burrell’s liquid media (BLM) was used, which contained: 
- Proteose peptone                                10g 
- Meat  extract                                        5g 
- Sodium chloride                                   5g 
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- Yeast extract                                         1g 
- Glucose                                                 2g 
 
2.2.2.4.  Production of C. pseudotuberculosis culture : 
The fermenter parts were assembled after autoclaving,  A temperature of 31º C, pH 
of 8.0 and dilution rate at 0.02 h-¹ were adjusted. The volume of the media in the 
system was 500 ml. The system circulated, samples were taken daily and smears 
were stained with Gram's stain to check purity. The harvested fermenter broth was 
collected in 0.3% formol saline (Bőhnel, 1999 and Suleiman, 2001).  
2.2.2.5. Filtration of harvested   fermenter broth: 
For separation of cells and toxins polypropylene hallow fiber filters (FRESENIUS, 
St. Augustin) SPS900 (MWCO/1000 kDa) and SPS600 (MWCO/100 kDa) were 
used. Two phases of filtration were done to obtain purified and concentrated 
products from the formalinized fermenter broth, which could be carried out either 
simultaneously or separately. In phase 1 the bacterial cells were separated from the 
medium which contains  remaining medium ingredients, toxoid and metabolic 
products. In phase 2, further filtration to purify and concentrate toxoid by 
discarding low molecular weight proteins, the rest of medium components and 
water.     
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Fig. 3: An illustration for filtration system set-up (Bőhnel, 1999). 
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2.2.3. Viable cell count: 
The viable cell count of C.pseudotuberculosis in samples from the bioreactor was 
determined according to Miles and Misra (1938), it was found to be 1.5 x 108 
CFU/ml.  
2.2.4. Components of different  vaccines:  
Five types of vaccines were prepared by different combinations from three 
components; whole cell, cell wall lysate and toxoid. 
2.2.4.1. Whole cell: 
After collection and  filtration of harvested fermenter broth, separated cells were 
washed with distilled water and stored at 4º C as whole cell concentrate. 
2.2.4.2. Cell wall lysate: 
Whole cell concentrate was  twice with acetone and twice with diethyl ether. The 
cells were then disrupted either by shaking with glass beeds by means of an 
electronic shaker ( Edmond, Germany) and/ or by sonicator (MSE, England). 
Trypsin 1ug/ml was added and the suspension was incubated at 37º C for six 
hours. By centrifugation, the cell wall lysate was pelleted, and then washed three 
times in distilled water. The lysate was examined microscopically after staining by 
Gram’s to detect intact cells. 
                    2.2.4.3. Toxoid: 
From the formalinized fermenter  broth harvest toxoid  was collected by filtration, 
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the protein content was determined for the toxoid, then incubated at 37º C for 45 
days during which the formalin concentration of 40g/l which corresponding 0.3% 
formalin  was maintained. After that the toxoid was stored at 4º C 
2.2.5. Determination of protein content for vaccines: 
The protein content was estimated according to Lowry et al. (1951) 
method which depends on detection of tyrosine content that is constant in 
many proteins. 
2.2.5.1. Reagents: 
     - N. Na OH containing 2% anhydrous Na2 Co3. 
     - 2% sodium /potassium tartarate solution. 
     - 1% Cu So4 solution.  
     - Bovine serum albumin (BSA), 1mg/stock solution. 
     - Folin Ciocalteu phenol reagent (BDH) diluted 2:5 distilled water. 
All reagents were prepared in distilled water. Lowry solution was 
prepared by adding 50 ml of 0.1 N Na OH containing 2% anhydrous      Na2 
Co3 solution A, to 0.5ml of 2% sodium /potassium tartarate solution B, Then 
0.5 ml of 1% Cu So4 was added 
        2.2.5.2. Procedures: 
The bovine serum albumin (BSA) was used as standard protein and was 
prepared by dissolving 50 mg of BSA in 50 ml volumetric flask to give a 
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stock solution of 1 mg protein per 1 ml and the following dilutions were made 
in test tubes, 200 μg/ml, 400 μg/ml, 600 μg/ml 860 μg/ml, 1000      μg/ml. 
Likewise, in separate test tubes 1/5, 1/10  and 1/20 dilutions of the unknown 
solutions “whole cell, cell wall lysate and toxoid” were made. From each 
dilution of the standard protein or the solution under test, 0.1 ml was pipetted 
separately into fresh test tubes and the volume was brought to 0.4ml by 
addition of  0.3 distilled water. All tests were made in duplicates. The final 
concentration of the standard protein were 20, 40, 80, 100 micrograms 
protein. For blank 0.4 ml of distilled water was put into two test tubes. To the 
standard and each dilution of the test solutions, 2ml of Lowery solution was 
added. The tubes were mixed well and incubated at room temperatures for 10 
minutes in order to allow protein hydrolysis. Then to each tube, 0.2 ml of 
Folin Ciocalteu phenol reagent diluted 2:5 with distilled water was added. 
Test tubes were mixed and immediately kept in the dark for 30 minutes. 
Absorbance of each standard and test solution was read in a 
spectrophotometer (Milton Roy, U.S.A), using 1cm path at 560 nm. 
A standard curve was blotted using protein value against absorbance of 
standard protein. The protein value of the toxin was estimated from the 
standard curve. 
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2.3. Vaccination trials: 
2.3.1. Experimental animals:  
Forty two sheep of local types at ages from six months to one year old, 
weighing (15-30kg) and seronegative for C.pseudotuberculosis by the 
bacterial agglutination test, were bought from the local market. The animals 
were divided at random into 6 groups, 7 sheep each. They were kept in pens, 
and dewormed. Feed and water were provided ad libitum and observed for 
adverse clinical signs for five weeks before vaccination. 
2.3.2. Composition of vaccines: 
2.3.2.1. Types of the vaccine: 
Five types of vaccines were prepared as follows: 
(i) Whole cell vaccine that a dose of 0.5 ml contained 8 mg  of dry weight.  
(ii) Cell wall vaccine that a dose of 0.5 ml contained 3 mg of protein. 
(iii) Toxoid vaccine that a dose of 0.5 ml contained 4 mg of protein. 
(iv) Cell wall and toxoid vaccine of which a dose of 1 ml composed of cell wall (3 
mg protein) + toxoid (4 mg protein). 
(v) Whole  cell and toxoid vaccine of which a dose of 1 ml composed of whole cell 
( 0.5 ml/8 mg dry weight) + toxoid (0.5 ml/4 mg protein). 
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2.3.2.2. Adjuvant used: 
The saponin and aluminum hydroxide (Al (OH)3 ) were incorporated into each 
vaccine at a dose rate of 1mg/1ml each.   
2.3.2.3. Vaccination protocols: 
The five groups of animal were administered  the first dose subcutaneously at the 
shoulder region as fellow: 
- Each animal in the first group was injected with 0.5 ml dose of  the whole 
cell (WC) vaccine. 
- In the second group with 0.5 ml  dose of the cell wall (CW) vaccine. 
- In the third group with 0.5 ml dose of the toxoid (T) vaccine. 
- In the fourth group with 1 ml dose of the cell wall and toxoid (CW+T) 
vaccine. 
- In the fifth group with 1 ml dose of the whole cell and toxoid (WC +T) 
vaccine and the sixth group was left unvaccinated control. 
After four weeks a booster dose of each vaccine was injected similarly into each 
animal in the five groups.    
2.3.3. Challenge of vaccinated animals: 
2.3.3.1. Preparation of the challenge doses: 
C.pseudotuberculosis strain CP41N was cultured on blood agar, incubated at 37℃ 
for  48 hours; then one colony was transferred with a sterile wire loop to the brain 
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heart infusion broth containing 0.1% Tween 80 and incubated at 37℃ for 24 hours. 
Ten-fold serial dilutions of the culture   were made in normal saline and with a 
pipette, 0.1 ml amounts  were cultured from dilutions 10
-6
, 10
-7
 and 10
-8
  onto 
blood agar plates in duplicates. After culture the plates were dried in the incubator 
for one hour, and then incubated at 37℃ for 48 hours. Colony-forming units (CFU) 
from each plate were counted using a colony counter (Gallenkamp, England) 
means values were determined.  
   Hence a challenge dose for each animal was determined  to be 5.1X10
8   
CFU
 
of C.pseudotuberculosis strain CP41 N.  
2.3.3.2. Inoculation of challenge doses:   
One month after the booster dose of each vaccine, all sheep of the six groups 
were challenged with the determined challenge dose, each administered  
subcutaneously on the left side of the neck of each animal. 
2.3.4. Serology: 
2.3.4.1. Bacterial agglutination test (BAT): 
2.3.4.1.1. Preparation of whole cell antigen: 
C.pseudotuberculosis strain CP41N was cultured at 37℃ onto brain heart infusion 
(BHI) agar containing 0.1% sorbitan mono-oleate. The 24- hours growth was 
transferred to BHI broth containing 0.1% sorbitan mono-oleate and incubated with 
 77 
constant stirring for six hours at 37℃. The culture was centrifuged at 3000 rpm for 
15 minutes. The packed bacterial cells were washed two times in PBSS at pH 7.2 
containing 1.0% sorbitan mono-oleate and 0.3% formalin, and then suspended in 
PBSS at the same pH containing 1.0 % sorbitan mono- oleate (Keskintepe, 1976) 
and 0.2 % formalin and diluted to 80% transmittance with a spectrophotometer   
(Milton Roy, U.S.A) at (600 nm) wave length (Lund et al., 1982). 
2.3.4.1.2. Test procedure: 
Double dilutions of each test serum were made from: 
1
/5, 
1
/10, 
1
/20  to  
1
/320  in 0.5 ml 
PBSS at pH 7.2 with 0.1% sorbitan mono-oleate, 0.5ml of cells suspension were 
added. The mixture was incubated overnight in a water bath at 37℃ and examined 
visually for agglutination and clearing of the supernatant. Pooled sera from three 
infected sheep were used as a positive control. 
2.3.5. Autopsy of sheep after challenge: 
All animals of the six groups were slaughtered four weeks after challenge to  
evaluate and compare levels of protection, in comparison to   non vaccinated  
control sheep.  As CLA is characterized by abscesses formation in lymph nodes  
draining the part of C. pseudotuberculosis entrance therefore, the challenge site,  
the main draining lymph nodes and internal organs of carcasses were thoroughly  
examined for CLA pyogenic lesions or abscesses. Samples from of lesions were  
collected aseptically for bacteriological examinations. 
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2.3.6. Calculation of protective capacity of vaccines: 
      The capacity of vaccines to protect animals against infection when less than 
100% of susceptible controls become affected after challenge  can be expressed as 
a protection percentage using this formula: 
Percentage protection = % of infected control – % of infected vaccinates X 100              
                                                   % of infected controls 
 
2.3.7. Statistical analysis: 
Appearance of abscesses in the control group and groups of animals vaccinated  
with WC, CW, T, CW + T, and WC + T was evaluated statistically using Analysis  
of variance (ANOVA). 
 
 2.4. Antibiotic Sensitivity Tests: 
2.4.1. Strains used: 
Sixty six strains of C. pseudotuberculosis  isolated in the study area, were selected  
randomly to be tested for antibiotic sensitivity. 
2.4.2. Test procedures: 
 A colony of each C. pseudotuberculosis was transferred from blood agar to 5ml 
nutrient broth and incubated at 37 C for 24 hours. Two drops from this broth were 
mixed with 5 ml of normal saline and 1 ml of the mixture was spread over DST 
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agar (Oxoid 0261). The plates were left for 5 minutes before excess fluid was 
removed using a sterile pipette. Antimicrobial discs were dispensed on each plate 
with  sterile forceps. The diameter of inhibition zone around each antimicrobial 
disc was measured with calipers in millimeters.       
2.5. Polymerase chain reaction ( PCR):  
2.5.1. DNA extraction: 
 
TNES buffer: 
 
 -    100 mM Tris Hcl  (pH 7.6) 
 
 -      40 mM EDTA 
 
   -         50 mM Nacl 
 
   -          SDS    0.2% 
 
Chromosomal DNA extraction was made in the same manner for all the  
 
selected  28 C. pseudotuberculosis strains. A 20 ml 48–72 h culture of each strain  
 
was centrifuged at 4 °C and 6000 rpm for 20 minutes. The supernatant was  
 
discarded and 800 µl of TNES buffer and 10 µl of  proteinase K (10mg/ml) were  
 
added to the precipitate which was incubated over night at 37 °C or at 65 °C for 2  
 
hours. An equal volume of phenol/chloroform/isoamyl alcohol was added, mixed  
 
and centrifuged at 6000 rpm for 5 minutes. The upper layer was transferred to a  
 
clean tube, before an equal volume of phenol /chloroform/isoamyl alcohol was  
 
added. The mixture was  centrifuged at 6000 rpm for 5 minutes and the upper layer  
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was transferred to a clean tube. Two volumes of 95% cold ethanol and 1: 10 of  
 
sample volume of 3M Sodium acetate were added and the tubes were incubated  
 
over night or at –20°C for 2 hours then centrifuged for 10 minutes at 12000 rpm.  
 
The supernatant was discarded and 2 ml of 70% ethanol were added. The tubes  
 
were then centrifuged for 7 minutes at 12000 rpm and the supernatant was  
 
discarded. The previous step was repeated one more time before the supernatant  
 
was discarded and the pellet allowed to dry for 15 minutes and100 µl of TE buffer  
 
or deionized water was added and stored at -20° C till use. 
 
2.5.2. Concentration of DNA: 
 
The quantity of DNA for every sample  was read by Nano Drop 
  
spectrophotometer ND- 100, depending on DNA reading either 2.5 or 5 µl was 
 
taken for the PCR. 
 
2.5.3. Primers design: 
 
The primers used in this study were targeting the published 16S rRNA gene  
 
sequences of C. pseudotuberculosis (GenBank). According to Çetinkaya, (2002)  
 
the selected primers with a length of approximately 20 bp, an optimal annealing  
 
temperature between 50 and 60° C, and a GC-content between 20 till 80%  . The  
 
resulting forward primer was; 
 
 ACCGCACTTTAGTGTGTGTG (E. coli position 183–203) 
 
 and the reversed primer had the sequence: 
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TCTCTACGCCGATCTTGTAT (E. coli position 1019–999)  
 
and the annealing temperature was 55°C. The specificity of the primers was  
 
checked by comparing their sequences to all known sequences in GenBank  
 
 (Çetinkaya, 2002). 
 
2.5.4. PCR  mixture: 
 
The total reaction volume was 25 µl  which contained: 
 
    - 5µl of 10 × Vi buffer A (Vivantis, DNA Amplification products) 
 
    - 5 µl  of 5 mM MgCl2 
  
      -1 µl  of 10 mM deoxynucleotide triphosphate (dNTPs) (Vivantis, 
   
                  Nucleotides) 
 
     - 0.4  µl of Taq DNA polymerase (Vivantis) conc. 5 µl/µl 
 
 
     - 1  µl of 100 mM of each primer ( Vivantis technologies Sdn.Bhd.,  
            
                     Malaysia) 
 
      -5 or 2.5 µl of template DNA. 
 
 
2.5.5. PCR conditions: 
 
The PCR was performed in a touchdown thermocycler (Advanced primus 
 
 96, Peq lab Biotechnologie, Germany)  
 
 Amplification was obtained with 30 cycles following an initial denaturating  
 
step at 94° C for 5 minutes.  
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Each cycle involved: 
 
 - Denaturation at 94° C for 1 minute. 
 
 - Annealing at 56° C for 1 minute.  
 
 - Synthesis at 72° C for 2 minute. 
 
 
2.5.6. Detection of PCR product:  
 
By using gel electrophoresis the amplified products for elected strains with both 
 
 positive wild strain and negative control were detected by ethidium bromide (0.5  
 
mg/ml) staining after electrophoresis at 60–70 V for 1 h in 1.5% agarose gels. An  
 
automated photo documentation system ( Bio. Doc. Analyza, digital) was used for 
 
 analysis.  PCR products with the molecular size of 815 bp were considered  
 
indicative for identification of C. pseudotuberculosis.  
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Appendix 
 
 
 
1. Culturing and identification: 
1.1. Culture Media: 
1.1.1. Solid media: 
1.1.1.1. Blood agar base No. 2 (Oxoid CM55):  
Ingredients: g. per 1 liter  
Proteose peptone  15g 
Liver digest 2.5g 
Yeast extract 5g 
Sodium chloride 5g 
Agar No.3 12g 
pH 7.4(approx) 
Forty grams were suspended in one liter of distilled water, brought to 
boil to dissolve the ingredients completely, mixed and sterilized by 
autoclaving at 121℃ for 15 min. Then cooled to 45-50℃ and 7% 
defibrinated ovine blood was added, mixed gently and the media was 
dispensed in sterile petri-dishes in amounts of 15 ml each. 
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1.1.1.2. Brain heart infusion agar (Oxoid CM375): 
Ingredients: g. per 1 liter: 
Calf brain infusion solids 12.5g 
Beef heart infusion solids 5.0g 
Proteose peptone (Oxoid L46)  10.0g 
Sodium chloride 5.0g 
Dextrose 2.0g 
Disodium phosphate 2.5g 
Agar No.1 (Oxiod L11) 10.0g 
pH 7.4 (approx.) 
Forty-seven grams were suspended in 1 liter of distilled water, boiled to 
dissolve the ingredients completely, and (0.1% v/v) Sorbitan mono-
oleate (Tween 80) was added. The medium was autoclaved at 121℃ for 
15 minutes then poured in sterile petri-dishes in amounts of 15 –20 ml. 
 
1.1.1.3. Nutrient agar (Oxoid CM3, R2): 
Ingredients: g. per 1 liter  
Peptone 5.0g 
Yeast extract 5.0g 
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Lab Lemco powder 1.0g 
Sodium chloride 5.0g 
Agar No.1 15.0g 
An amount of 8.0 g  were suspended in 1 liter of distilled water and 
brought to boil to dissolve completely. The pH was adjusted to 7.4±0.2 
and the preparation was sterilized by autoclaving at 121℃ for 15 
minutes, then cooled to 45-50℃ and distributed into sterile petri- dishes 
in about 20 ml each. 
 
1.1.1.4. Urea agar base (Oxoid CM53, R3):  
Ingredients: g. per 1 liter  
Peptone (Oxoid 37) 1.000g 
Dextrose 1.000g 
Na2 HPO4 1.200g 
KH2 PO4 0.800g 
Sodium chloride 5.000g 
Agar No.3 (Oxoid L 13) 15.000g 
Phenol red 0.012g 
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An amount of 2.4 g  were suspended in 95 ml of distilled water and 
brought to boil to dissolve completely and the pH was approximately 
adjusted to 6.8. The medium was sterilized by autoclaving at 115℃ for 
20 min., cooled to 50℃ and aseptically 5 ml sterile 40% urea solution 
were added and mixed well. The medium was then distributed in 10 ml 
amounts into sterile MacCartney bottles and allowed to set in slope 
position. 
       1.1.1.5. Serum agar slant: 
The medium was prepared according to Cowan (1993) by the addition 
of 10% sterile horse serum to melted nutrient agar. 
1.1.1.6. Dorset egg medium (Oxoid PM5): 
Ingredients: 
Fresh egg mixture (yolk + white) 750 ml 
Nutrient broth powder (Oxoid) 250 ml 
 
The eggs were washed thoroughly with soap and water, soaked in 70% 
alcohol for 30 minutes, then layered on sterile surface. The shell was 
broken at the narrow end with sterile knife, the contents were let to fall 
into sterile flask, and then shaken thoroughly to break up the yolk and 
to produce a homogeneous mixture. The nutrient broth powder was 
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suspended in 250 ml distilled water, boiled to dissolve completely and 
then added to the egg mixture and mixed well avoiding bubbles 
formation. The medium was then distributed in sterile MacCartney 
bottles in amounts of 5-7 ml each. For sterilization of the medium, the 
bottles were sloped in the upper part of steamer until the slant has been 
formed and then left for 1 hour in the steamer. The procedure was 
repeated for two successive days. 
 
1.1.2. Liquid media: 
1.1.2.1. Nutrient broth (Oxoid CM1, R1): 
Ingredients: g. per 1 liter  
Peptone 5.0g 
Yeast extract 2.0g 
Lab Lemco powder 1.0g 
Sodium chloride 5.0g 
Thirteen grams were added to one liter of distilled water, and mixed 
well to dissolve. The pH was adjusted to 7.4±0.2 and the preparation 
was then distributed in test tubes in 10 ml amounts and sterilized by 
autocalving at 121℃ for 15 min.  
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1.1.2.2. Brain heart infusion broth (Oxoid CM225): 
        Ingredients: g. per 1 liter  
Calf brain infusion solids 12.5g 
Beef heart infusion solids 5.0g 
Proteose peptone (Oxoid L46)  10.0g 
Sodium chloride 5.0g 
Dextrose 2.0g 
Disodium phosphate 2.5g 
pH 7.4 (approx.) 
Thirty-seven grams were added to 1 liter of distilled water and boiled to 
dissolve the ingredients completely before 0.1%( v/v) Sorbitan mono-
oleate (Tween 80) was added to the medium. The medium was then 
mixed well and distributed into MacCartney or universal bottles and 
sterilized by autoclaving at 121℃ for 15 minutes. 
1.1.2.3. Robertson’s cooked meat medium (Cowan, 1974): 
Minced meat 1000g 
0.05-N- Na OH 1000ml 
 
Clean fat free lean meat was minced into small particles and added to 
the alkali solution Na(OH), mixed well and heated to boiling, simmered 
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for 20 minutes  with frequent stirring, skimmed off any fat and the pH 
was adjusted to 7.5, strained through gauze, dried, distributed in screw 
capped bottles and sufficient nutrient broth was added to cover the meat 
to 2 cm above. The medium was then sterilized by autoclaving at 115℃ 
for 20 minutes.  
1.1.2.4. Nitrate broth (Cowan, 1993) 
Ingredients: g. per 1 liter  
K NO3 1 g 
Nutrient broth 1000 ml 
KNO3 was dissolved in nutrient broth, distributed into sterile test tubes 
and sterilized by autoclaving at 115 ℃ for 20 min.  
1.1.2.5. Peptone water sugars (Cowan, 1993): 
Peptone 900 ml 
Andrade’s indicator 10 ml 
Sugar 10 g 
Distilled water 90 ml 
pH 7.1 (approx.) 
The sugar was added to the mixture of peptone plus indicator, mixed 
thoroughly, then distributed in portions of 2 ml in sterile test tubes with 
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an inverted Durham tube, and then sterilized by autoclaving at 10/lb 
pressure for 10 minutes. 
2. Reagents 
2.1. Hydrogen peroxide:   
Obtained  from British Drug House (BDH) Company, England. It was 
prepared as 3% aqueous solution and used for catalase test. 
2.3. Nitrate test reagents: 
These were composed of two solutions. 
Solution (A): 
0.8% sulphanilic acid in acetic acid. This was prepared by mixing 0.4 
ml of sulphanilic acid in 50 ml of 5N- acetic acid. 
 Solution (B): 
0.5% dimethyl-α- nephthylamine  in 5N-acetic acid. 
2.4. Solutions : 
2.4.1. Normal saline (0.85%): 
It was prepared by dissolving 8.5 gm of sodium chloride in one liter 
distilled water then sterilized by autoclaving at 121℃ for 15 min. 
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2.4.2. Phosphate buffered saline solution (PBSS) 
It was prepared by dissolving the following ingredients: 
Sodium chloride 8 g 
Potassium chloride 0.2g 
Di Sodium hydrogen phosphate (Na2 Hpo4) 1.15g 
Potassium dihydrogen phosphate (KH2 PO4) 0.2g 
The ingredients were dissolved in one liter of distilled water and 
sterilized at 121℃ for 15 minutes. 
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2. Mass Cultivation of C. pseudotuberculosis using IBT Bioreactor: 
 
 
 
Appendix Fig. 1: An illustration  of Goettingen IBT bioreactor set-up for bacterial 
mass production (Bőhnel, 1999).
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3.2.3. Results of statistical analysis: 
 
 
 
Appendix table 1 : Means of abscesses in vaccinated and control animals 
 
 
 
 
Animal 
group 
  Means
 a
  of abscesses 
Site of 
challenge  
Prescap.
L.N. 
Lung Liver Mediastinal 
L. N. 
Omentum Precrural 
L.N. 
Subcutaneous Total 
G1(CW) 1.0000 
a
  0.1667 
a
 0.3333 
a
 2.6670 
b 
0.0000 
a 0.0000 a 0.0000 a 0.0000 a 4.16700 c 
G2(WC) 0.8000 
a
 0.2000 
a
 0.0000 
a
 1.6000 
b 
0.0000 
a 0.0000 a 0.2000 a 0.0000 a 3.5000 c 
  G3( T )    0.5000 
a
 0.0000 
a
 1.0000 
a
  8.5000 
a
 0.0000 
a 0.0000 a 0.0000 a 0.0000 a 10.0000 a 
G4(CW+T) 1.0000 
a
 0.2500 
a
 0.0000 
a 1.7500 b 0.0000 a 0.0000 a 0.0000 a 0.0000 a 3.0000 c 
G5(WC+T) 0.8000 
a
 0.0000 
a
 0.0000 
a 0.0000 b 0.0000 a 0.0000 a 0.0000 a 0.0000 a 0.8000 d 
G6(control) 1.0000 
a
 0.2000 
a
 1.2000 
a 3.6000 a 0.2000 a 0.1000 a 0.2000 a 0.4000 a 7.8000 a 
 
L. N. = Lymph node                                                   
 
Meansª followed by the same letter in each column are not significantly different (P > 0.05)  
(Duncan Grouping) 
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3.3. Antimicrobial susceptibility results: 
 
 
   
 
Appendix table 2:  Antibiotic sensitivity test results of the C. pseudotuberculosis 
isolates. 
 
Sensitive       
>18mm     
Moderate    
12—18 mm    
Resistant     
<12mm        
Antibiotic 
concent. 
Antibiotic       
          
%   
          
No. 
      
 %       
        
No.      
       
%     
      
 No.     
  
78.8% 52/66   21.2% 14/66 0.0% 0/66         10 µg    Chloramphenicol 
72.1% 44/61   26.2% 16/61 1.7% 1/61      5 µg    Erythromycin      
66.2% 43/65   33.8% 22/65 0.0% 0/65      10 µg     Ampicillin            
88.9% 32/36   8.3% 3/36  2.8% 1/36      30 µg    Oxytetracycline   
78.4% 29/37   21.6% 8/37  0.0% 0/37      2 µg    Rifampacin           
0.0% 0/66    12.1% 8/66  87.9% 58/66     1   iu    Penicillin               
0.0% 0/66   27.3% 18/66  72.7% 48/66     10 µg   Streptomycin        
21.6% 11/51  66.7% 34/51  11.7% 6/51      30 µg   Kanamycin          
27.0% 10/37  70.3% 26/37  2.7% 1/37       Methicillin           
2.0% 1/50   22.0% 11/50  76.0% 38/50    5 µg   Cloxacillin          
30.3% 20/66  65.2% 43/66  4.5% 3/66     10 µg   Gentamycin        
86.7% 13/15  13.3% 2/15  0.0%  0/15     200 µg   Nitrofurantoin    
78.6% 11/14   21.4% 3/14  0.0% 0/14      25 µg   Cotrimexazole     
0.0% 0/15   0.0% 0/15  100% 15/15    30 µg   Nalidixic acid    
0.0% 0/15   0.0% 0/15  100% 15/15     25 µg   Colistin               
0.0% 0/33   6.1% 2/33  93.9% 31/33    30 µg  Novobiocin        
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Chapter Three 
Results 
 
 
 
 
3.1. Results of field survey: 
 
3.1.1. The prevalence of C.pseudotuberculosis among live and slaughtered               
sheep 
 
Of the 54  samples of pyogenic aspirates collected from enlarged lymph  
 
nodes of live sheep at local animal markets in Nyala and 89 samples of abscess  
 
collected from sheep carcasses during meat inspection at Nyala slaughterhouse  
 
C. pseudotuberculosis was isolated from 38 (70.4%) of the live sheep and  
 
58 (65.2%) of the slaughtered sheep. The prevalence of CLA was  
 
0.6% for live sheep and 1.7% for slaughtered sheep. The over all prevalence of  
 
disease in sheep was 1%. (Table 1). 
 
 
3.1.2. The prevalence of C.pseudotuberculosis among live and slaughtered    
goats:  
 
Of the 34 pyogenic aspirates collected from enlarged  
 
lymph nodes of live goats at local animal markets in Nyala and 6 samples of   
 
pus from infected lymph nodes collected from goats carcasses during meat  
 
inspection at Nyala slaughterhouse, C. pseudotuberculosis was isolated from 58  
 
(65.2%) of live goats and 5(83.3%) of slaughtered goats. The prevalence of  
 
CLA was 0.6% for live goats and 2.7% for slaughtered goats.  
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The over all prevalence of the disease in goats was 0.7% (Table 2).  
 
3.1.3. Distribution of CLA lesions in sheep and goats: 
 
Eighty nine  lesions of CLA in inspedcted   slaughtered sheep were  
 
distributed as follows: 58 (65.2%) in prescapular, 13(14.6%) in precrural,  
  
6 (6.7%) in parotid, 5 (5.6%) in supramammary, 1 (1.1%) in mandibular, 1 (1.1%)  
 
in mediastinal, 1(1.1%) in mesenteric lymph nodes,  2 (2.2%) subcutaneous  
 
abscesses, 1 (1.1%) in liver and 1 (1.1%) in lung.  Fifty two  lesions of CLA in  
 
examined live sheep were distributed as follows: 15(28.8%) in parotid, 13(25%) in  
 
prescapular, 7(13.5%) in mandibular, 3(5.8%) in precrural lymph nodes and  
 
14(26.9%) subcutaneous abscesses. The over all distribution of 141 lesions in  
 
slaughtered and life sheep together were found to be 70 (50.4 %),  in  prescapular  
 
20(14.9 %) in parotid, 16(11.3%) in precrural, 8(5.7%) in mandibular,  
 
 5 (3.5%) in supramammary, 1(0.7%) in mediastinal, 1(0.7%) in mesenteric lymph  
 
nodes, 1(0.7%) in liver, 1(0.7%) in lung and 16(11.3%) subcutaneous abscesses  
 
(Table 3). 
 
    Whereas in slaughterd goats, 6 lesions were found, 4 (66.7 %) in parotid  
 
and 2 (33.3 %) in prescapular lymph nodes. Thirty four lesions of CLA in live  
 
goats were distributed as follows: 17(50%) in prescapular , (23.5%) in parotid,  
 
5(14.7%) in mandibular, 4(5.9%) in precrural lymph nodes and 4(5.9%)  
 
subcutaneous abscesses.  The over all distribution of 40 lesions  
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in slaughtered and life goats was 19 (47.5 %) in prescapular, 12 (30 %) in parotid  
 
, 4 (10 %) in precrural, 5 (12.5 % ) in mandibular lymph nodes, and 4 (10 %)   
 
subcutaneous abscesses  (Table 4).  
                             
3.1.4. Identification of bacteria: 
The criteria used for the identification of isolates were as follows: 
3.1.4.1. Morphology and Staining: 
The organism appeared in stained smears as Gram-positive, small rods, 
tending to form clumps resembling Chinese letters in arrangement. It was 
non-motile, non-spore-forming. 
3.1.4.2. Cultural characteristic: 
3.1.4.2.1. On blood agar medium: 
After 48 hours at 37℃, growth was in the form of small tiny colonies (about 
1mm in diameter). Colonies were white, opaque, flat and waxy in consistency. 
They splattered on flaming and were easily pushed across the agar surface. 
3.1.4.2.2. Brain heart infusion broth: 
The growth extended on the sides of the tube, forming a pellicle and granular 
sediment with no general turbidity. 
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Table 1: Number of live and slaughtered sheep with abscesses and CLA. 
 
 
 
Total No. 
of animals 
examined 
No. of 
animals with 
abscesses 
% of animals 
with 
abscesses 
No. of +ve for 
C.pseudotuberc
ulosis 
% of +ve for 
C.pseudotuberculo
sis among affected 
animals 
%  of +ve for 
 C.pseudotuberculosis 
 among total animal 
Live Sheep 6560 52 0.8 % 38 73.1 % 0.6 % 
Slaughtered 
Sheep 
3324 89 2.8 % 58 65.2 % 1.7  % 
Total 9884 141 1.4 % 96 68.1 % 1   % 
 
CLA: Caseous lymphadenitis 
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Table 2: Numbers of live and slaughtered goats with abscesses and CLA. 
 
 
 
Total No. 
of animals 
examined 
No. of 
animals with 
abscesses 
% of animals 
with 
abscesses 
No. of +ve 
C.pseudotuberc
ulosis 
% of +ve for 
C.pseudotuberculo
sis among affected 
animals 
%  of +ve for 
 C.pseudotuberculosis 
 among total animal 
Live Goats 4450 34 0.8 % 27 76.5 % 0.6 % 
Slaughtered 
Goats 
  184   6 3.3%   5 83.3 % 2.7  % 
Total 4634 40 0.86 % 32 80 % 0. 7 % 
 
CLA: Caseous lymphadenitis 
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Table 3: Distribution of CLA lesions  in live and slaughtered sheep.                        
         
 Total No. of 
lesions 
Prescapular 
L. N. 
Parotid 
 L. N. 
Precrural 
 L. N. 
Mandibular 
L. N. 
Mediastinal 
L. N. 
Mesenteric  
L. N 
Supramammary 
 L. N. 
liver lung Subcutaneous 
abscess 
Slaughtered 
sheep 
89 58 6 13 1 1 1 5 1 1 2 
% - 65.2% 6.7% 14.6% 1.1% 1.1% 1.1% 5.6% 1.1% 1.1% 2.2 
Live sheep 52 13 15 3 7 - - - - - 14 
% - 25 % 28.8% 5.8 % 13.5 % - - - - - 26.9 % 
Total 141 71 21 16 8 1 1 5 1 1 16 
Over all % - 50.4 % 14.9%  11.3% 5.7% 0.7% 0.7% 3.5% 0.7% 0.7% 11.3% 
 
L.N : Lymph node 
CLA: Caseous lymphadenitis 
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Table 4: Distribution of CLA lesions in live and slaughtered goats. 
 
 Total No. of 
lesions 
Prescapular 
L. N. 
Parotid 
L. N. 
Precrural 
L. N. 
Mandibular 
L. N. 
Subcutaneous 
abscess 
Live goats 38 17 8 4 5 4 
% - 44.7% 21.1% 10.5% 13.2% 10.5% 
Slaughtered goats 6 2 4 - - - 
% - 33.3 % 66.7 % - - - 
Total 44 19 12 4 5 4 
Over all % - 43.2 % 27.3% 9.1% 11.4 % 9.1% 
 
L.N : Lymph node 
CLA: Caseous lymphadenitis 
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3.1.4.3. Biochemical tests: 
Isolates were positive to produce catalase,  hydrolysed urea, most of it were 
negative to reduce nitrate to nitrite. The isolates fermented glucose, fructose , 
mannose, maltose, galactose and were negative for salcin, trehalose and 
starch.  
 
3.2. Results of  vaccination trials: 
 
3.2.1. Serological responses to vaccines: 
 
The groups of animals were monitored for antibody titres by agglutination tests. 
The animals vaccinated with cell wall, whole cell, cell wall+ toxoid and whole 
cell+ toxoid showed serological responses. Titres began to increase and reached 
the primary peaks  two weeks post vaccination, then declined.  Other secondary 
peaks of the titres  were  observed one week after the booster doses. It was 
observed that in the four groups of animals vaccinated with cell wall, whole cell, 
cell wall + toxoid and whole cell+ toxoid the results of the agglutination tests 
showed similar pattern either in duration or degree of response, which could be 
considered of equal magnitude ( i. e ) a rise in agglutination titres was evident in 
the following first week, and by the end of the second week it began to fall and 
reached its lowest level by the end of the fourth week  (Figure 5). The titre in sheep 
vaccinated with toxoid and non-vaccinated control animals were unchanged until 
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challenge when inoculated s/c using virulent C.pseudotuberculosis CP41N, then 
the animals began to respond and the titres reached their peaks 2 weeks after s/c 
challenge 
3.2.2. Results of challenge: 
After three days of subcutaneous challenge with (5.1X10
8  
 CFU/ml) 
 
 of C.pseudotuberculosis strain CP41N of all sheep groups, three animals from the  
 
control group died. There were no abscesses at the sites of challenge or internal  
 
organs, but there were acute inflammation and distinct enlargements of the  
 
prescapular lymph nodes draining the site of challenge ( Figure 6). Six 
 
vaccinated animals  died from pneumonia before challenge, but there were  
 
no deaths among vaccinated animals after challenge.  
 
     Four weeks after challenge all remaining controls and vaccinated sheep  
 
were slaughtered. The distribution of abscesses and lesions in different organs  
 
(Figures 6, 7 and 8 ) were presented in (Table 5). Pus from the lesions were 
 
Positive  for C.pseudotuberculosis  upon culture.  
 
     The protection of the different vaccines were found to be 32.3%, 37.5%, 37.5%,  
 
45.3% and 75% in animals vaccinated with cell wall, whole cell, toxoid,  
 
cell wall +toxoid and whole cell + toxoid  respectively (Table 6).  
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Fig. 4: Agglutination titres of sheep  injected with the different C. pseudotuberculosis vaccines. 
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          Fig. 5: Abscess at site of  injection in a control sheep challenged with 
                  C. pseudotuberculosis  
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Fig. 6: Presacpular lymph nodes of a control sheep that had died after challenge with C. 
pseudotuberculosis. The lymph node on the right is the one that draining challenge injection 
site, the lymph node on the left is the one draining the other side. 
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Table 5: Abscesses in control and vaccinated sheep after       
                challenge with C. pseudotuberculosis. 
 
% of infected 
organs   
Total Subcut
absces. 
Precrural. 
L. N 
Omentum Mediastinal 
L. N. 
Liver Lung Prescapular 
L. N. 
Site of 
challenge  
Group  of the Animal 
                    Group 1, Cell Wall (CW) 
vaccine 
  37.5% 6    0     0     0     0     3      2     0       1           Animal1      
25%   3    0     0     0     0     2      0     0       1      Animal 2      
25%   2    0     0     0     0     0      0     1       1      Animal 3      
25%   10    0     0     0     0     9      0     0       1      Animal 4      
25%   2    0     0     0     0     1      0     0       1      Animal 5      
25%   2    0     0     0     0     1      0     0       1         Animal 6      
-     -     -     -     -     -     -      -     -            -        Animal 7*     
27.1%   25    0     0     0     0     16      2    1       6      Total       
           
                                  Group 2, Whole Cell 
(WC) vaccine   
 
37.5%   3    0     0     0     0     1     0      1       1       Animal 1       
-         -    0     0     0     0     0     0      0       0       Animal 2      
25%   3    0     0     0     0     2     0      0       1       Animal 3      
25%   6    0     0     0     0     5     0      0       1       Animal 4      
-         -     -     -     -     -     -     -     -       -       Animal 5*     
12.5%   2    0     1     0     0     0     0     0       1       Animal 6       
-         -    -     -     -     -     -     -     -       -       Animal 7*      
25%   14    0         1     0     0     8      0     1       4       Total        
* Animals died before challenge                                       
  ** Animals died within 3 days after challenge 
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Table. 5 ( Cont.):  Abscesses in control and vaccinated sheep after       
                challenge with C. pseudotuberculosis. 
% of infected 
organs 
Total Subcut 
absces 
Precrural. 
L. N 
Omentum Mediastinal 
L. N 
Liver Lung Prescapular 
L. N 
Site of 
Challenge  
Groups of the animal 
                                           Group 3, Toxoid ( T ) 
vaccine 
-        -     -     -     -     -     -     -     -        -       Animal 1*   
-        -     -     -     -     -     -     -     -        -       Animal 2*  
25%   14     0     0     0     0     12     2     0        0       Animal 3    
-        -     -     -     -     -     -     -     -        -       Animal 4*  
-        -     -     -     -     -     -     -     -        -       Animal 5*  
25%   6     0     0     0     0     5     0     0        1      Animal 6   
-        -     -     -     -     -     -     -     -        -       Animal 7* 
25%    20    0     0     0     0     17     2     0        1       Total           
           
                                            Group 4, Cell 
Wall+Toxoid (CW+T) 
vaccine 
12.5%   1      0     0      0      0      0      0      0        1      Animal 1   
-        -      -      -      -      -      -      -      -         -      Animal 2*  
25%    7      0      0      0      0      6      0      0        1       Animal 3   
-        -      -      -      -      -      -      -      -         -       Animal 4* 
12.5%  1      0      0      0      0      0      0      0        1       Animal 5   
   37.5% 3      0      0      0      0      1      0      1             1  Animal 6   
-       -      -      -      -      -      -      -      -        -       Animal 7* 
21.9%  12          0     0      0      0      7      0      1        4       Total          
   * Animals died before challenge                                       
  ** Animals died within 3 days after challenge 
 
Table. 5 ( Cont.):  Abscesses in control and vaccinated sheep after       
                challenge with C. pseudotuberculosis. 
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% of infected 
organs 
Total Subcut. 
absces. 
Precrural 
L. N 
Omentum Mediastinal  
L. N. 
Liver Lung Prescapular  
L. N 
Site of 
challenge 
Groups of the 
animal 
                                     Group 5, Whole 
Cell+Toxoid 
(WC+T) vaccine 
12.5%  1     0      0      0      0      0     0      0         1        Animal 1   
12.5%  1     0      0       0      0       0     0      0         1        Animal 2   
12.5%  1     0      0      0      0          0     0      0         1        Animal 3   
-        -      -      -      -      -      -      -      -         -        Animal 4*  
-        -      -      -      -      -      -      -      -         -        Animal 5*  
 0%          0      0      0      0      0      0      0      0         0        Animal 6   
12.5%   1         0      0      0      0      0      0      0         1        Animal 7   
 10%      4     0      0      0      0      0      0      0         4        Total          
           
                                                                     Group 6,  
Control. 
-         -      -       -       -     -       -        -       -        -        Animal 1** 
-         -      -       -       -     -       -        -       -        -        Animal 2** 
-         -      -       -       -     -       -        -       -        -        Animal 3** 
37.5%  15     0       0       0     0     13       1      0        1        Animal 4     
25%   2     0       0       0     0     0       1      0        1        Animal 5     
62.5%  8     0       1       0     0     1       4      1        1        Animal 6     
37.5%  8     2      0       5    0     0       0      0        1        Animal 7    
37.5%  4     0       0       0     1     2       0      0        1        Animal 8     
40%     37     2      1       5    1     55       6      1        5        Total          
   * Animals died before challenge                                   
  ** Animals died within 3 days after challenge 
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Table 6: Protection of vaccinated animals. 
 
 
    Animal group Total No. of 
organs 
Total No. of 
infected 
organs 
Percentage of 
infected organs  
Percentage of 
protection 
Group 1, Cell 
Wall (CW) 
vaccine  
48 13 27.1% 32.3% 
Group 2, Whole 
Cell(WC) vaccine 
  
32 8 25% 37.5% 
Group 3, Toxoid 
(T ) vaccine 
16 4 25% 37.5% 
Group 4, Cell 
Wall+Toxoid 
(CW+T) vaccine 
32 7 21.9% 45.3% 
Group 5, Whole 
Cell+Toxoid 
(WC+T) vaccine 
40 5 10% 75% 
Group 6,  
Control. 
40 16 40% 0% 
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3.2.3. Results of statistical analysis: 
 
3.2.3.1. Description: 
 
Mean  values of abscesses of vaccinated and control animals were presented in table 7.  
 
The distribution of abscesses in vaccinated and control animals were shown in figures 7  
 
and 8. 
 
 
 
 
 
Table 7: Mean values of abscesses in vaccinated and control animals 
 Descriptives
Total number of  abscess detected
6 4.1667 3.25064 1.32707 .7553 7.5780 2.00 10.00
5 2.6000 2.30217 1.02956 -.2585 5.4585 .00 6.00
2 10.0000 5.65685 4.00000 -40.8248 60.8248 6.00 14.00
4 3.0000 2.82843 1.41421 -1.5007 7.5007 1.00 7.00
5 .8000 .44721 .20000 .2447 1.3553 .00 1.00
5 14.4000 21.13764 9.45304 -11.8459 40.6459 2.00 52.00
27 5.4074 9.88884 1.90311 1.4955 9.3193 .00 52.00
G1 (CW)
G 2 (WC)
G 3 (T)
G 4
(CW+T)
G 5
(WC+T)
Control
Total
N Mean Std. Deviation Std. Error Low er Bound Upper Bound
95% Conf idence Interval for
Mean
Minimum Maximum
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Fig. 7: Histograms showing number of abscesses in control and vaccinated animals after 
challenge with C. pseudotuberculosis 
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Fig. 8: A histogram showing distribution of abscesses in control and vaccinated animals 
after challenge with C. pseudotuberculosis 
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3.2.3.2.Analysis of variance (ANOVA): 
 
The data was found to be not normally distributed, so it was transformed using log  
 
transformation and analysis of variance (ANOVA) was used to evaluate and compare  
 
the findings of the vaccinated and control  animals. The results   showed that the mean  
 
difference between groups was significant (P-value < 0.017) ( table 7). 
 
3.2.3.3. Least significant difference (LSD): 
When the least significant difference (LSD) was applied, it showed that the mean 
difference was significant (P-value < 0.05) when group 5 was compared with 
group 6 and group 3 and less significant when compared with group 1, 2 and 4, 
probably due to the small sample sizes (animals that died needed to be excluded). 
    Group 5 looked best and group 3 seemed to be the same as the control group, the 
others seemed to have intermediate effectiveness (Table 8). 
     From the analysis it could be concluded that group 5 vaccinated with  
 
(WC +T) was the most protected group. 
 
 
Table 8: Analysis of variance 
 
Total number of abscess detected     
 Sum of Squares df Mean Square F Sig. 
Between Groups 137.321 5 27.464 3.642 .017 
Within Groups 150.833 20 7.542   
Total 288.154 25    
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Table 9: Multiple comparisons between abscesses of vaccinated and control                                                 
 
                animals. Multiple Com parisons
Dependent Variable: Total number of  abscess detected
LSD
1.5667 1.66291 .357 -1.9021 5.0354
-5.8333* 2.24227 .017 -10.5106 -1.1560
1.1667 1.77267 .518 -2.5311 4.8644
3.3667 1.66291 .056 -.1021 6.8354
-.8333 1.77267 .643 -4.5311 2.8644
-1.5667 1.66291 .357 -5.0354 1.9021
-7.4000* 2.29764 .004 -12.1928 -2.6072
-.4000 1.84221 .830 -4.2428 3.4428
1.8000 1.73686 .312 -1.8230 5.4230
-2.4000 1.84221 .207 -6.2428 1.4428
5.8333* 2.24227 .017 1.1560 10.5106
7.4000* 2.29764 .004 2.6072 12.1928
7.0000* 2.37829 .008 2.0390 11.9610
9.2000* 2.29764 .001 4.4072 13.9928
5.0000* 2.37829 .048 .0390 9.9610
-1.1667 1.77267 .518 -4.8644 2.5311
.4000 1.84221 .830 -3.4428 4.2428
-7.0000* 2.37829 .008 -11.9610 -2.0390
2.2000 1.84221 .246 -1.6428 6.0428
-2.0000 1.94186 .315 -6.0507 2.0507
-3.3667 1.66291 .056 -6.8354 .1021
-1.8000 1.73686 .312 -5.4230 1.8230
-9.2000* 2.29764 .001 -13.9928 -4.4072
-2.2000 1.84221 .246 -6.0428 1.6428
-4.2000* 1.84221 .034 -8.0428 -.3572
.8333 1.77267 .643 -2.8644 4.5311
2.4000 1.84221 .207 -1.4428 6.2428
-5.0000* 2.37829 .048 -9.9610 -.0390
2.0000 1.94186 .315 -2.0507 6.0507
4.2000* 1.84221 .034 .3572 8.0428
(J) Treatment groups
G 2 (WC)
G 3 (T)
G 4 (CW+T)
G 5 (WC+T)
Control
G1 (CW)
G 3 (T)
G 4 (CW+T)
G 5 (WC+T)
Control
G1 (CW)
G 2 (WC)
G 4 (CW+T)
G 5 (WC+T)
Control
G1 (CW)
G 2 (WC)
G 3 (T)
G 5 (WC+T)
Control
G1 (CW)
G 2 (WC)
G 3 (T)
G 4 (CW+T)
Control
G1 (CW)
G 2 (WC)
G 3 (T)
G 4 (CW+T)
G 5 (WC+T)
(I) Treatment groups
G1 (CW)
G 2 (WC)
G 3 (T)
G 4 (CW+T)
G 5 (WC+T)
Control
Mean
Dif ference
(I-J) Std. Error Sig. Low er Bound Upper Bound
95% Conf idence Interval
The mean dif ference is  s ignif icant at the .05 level.*. 
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3.3. Antimicrobial susceptibility results: 
 
       It was found that 86.7% of the isolates of C.pseudotuberculosis tested 
 
were highly sensitive to nitrifurantoin, 78.8% to chloramphenicol, 78.8% to  
 
rifampacin, 78.6% to cotrimoxazole, 72.1% to erythromycin and 66.2% to  
 
ampicillin. 
 
       On the other hand 70.3% of the isolates were moderately sensitive to 
 
 methicillin, 66.7% to kanamycin, 65.2 to gentamycin and 59.1% to  
 
tetracycline. Whereas 100% of the isolates were resistant to nalidixic acid  and  
 
colistin, 93.3% to novobiocin, 87.9% to penicillin, 76% to cloxacillin and  
 
72.7% to Streptomycin (Figure 9). 
  
3.4. Results of PCR product: 
 
By passing the products of PCR in gel, strains of C. pseudotuberculosis  
 
showed the same designated molecular size (816 bp) for the primer  
 
 targeting the 16S rRNA gene of C. pseudotuberculosis, yet negative control 
 
 (reaction without template DNA) showed no results. Figures 10, 11, 12 and  
 
13 show results of samples  obtained from different strains. 
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Fig. 4: Susceptibility of C. pseudotuberculosis  to selected antibiotcs
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Fig.9: Antibiotic susceptibility tests results of the C. pseudotuberculosis isolates 
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                   1        2         3         4          5          6          7        8 
 
                                                      
 
Fig. 10: Results of PCR amplification of C. pseudotuberculosis  16S rDNA gene sequences on 
agarose gel-electrophoresis for strains: CP199N (2), CP201N (3), CP152N (4), CP41N (5), 
negative control (6),  strains: CP275N (7) and CP216N (8), whereas DNA marker ladder is in 
lane (1)    
 
 
 
 
 
 
 
 
 
 
                      1      2     3    4      5      6      7   8     9    10  11   12  13    14    15    16 
 
 
 
 
 
Fig. 11: Results of PCR amplification of C. pseudotuberculosis  16S rDNA gene sequences on 
agarose gel-electrophoresis for strains: CP165N (2), CP230N(3), CP209N (4), CP229N (5), 
CP187N (6), CP180N (7), CP160N (8), CP221N (9), CP148N (10), CP162N (11), CP196N (12), 
CP322N (13), CP144N (14), CP313N (15), CP153N (16),  whereas DNA marker ladder  is  in 
lane (1) 
 
 
 
 
                                
816 bp 816 bp 
816 bp 
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                         1       2          3      4       5         6        7       8        9      10      11       12    13   
 
     
 
Fig. 12: Results of PCR amplification of C. pseudotuberculosis  16S rDNA gene sequences on 
agarose gel-electrophoresis for strains CP41N (2), CP144N (3), CP148N (4), CP153N (5), 
CP160N (6), CP162N (7), CP196N (8), CP214N (9), CP221N (10), CP313N (11), CP322N (12) 
and negative control (13), whereas DNA marker ladder is in lane (1). 
 
 
 
 
 
                                                       1  2    3    4    5    6   7   8    9   10 11 12 
                                                   
 
 
 
Fig. 13: Results of PCR amplification of C. pseudotuberculosis  16S rDNA gene sequences on 
agarose gel-electrophoresis for strains CP214N (2), negative control (3), CP41N (4), CP64N (5), 
CP65N (6), CP229N (7), CP203N (8), CP47aW (9), CP47bW (10), CP187N (11) and CP180N 
(12) whereas DNA marker ladder is in lane (1). 
 
 
 
 
 
 
 
 
816 bp 
816 bp 
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Chapter Four 
 
Discussion 
 
 
 
 
      Caseous lymphadenitis causes great economical losses in sheep and  
 
goats’ production due to condemnation of animals or parts of carcasses  
 
because of the infection. It affects animal trade as detection of the external  
 
disease in few animals leads to rejection of whole sheep export shipment and  
 
internal lesions may not be detected till after slaughter. Surgical treatment of  
 
the disease is not successful as it causes extensive fibrosis at the site of  
 
infection and the disease may recurs. Moreover, lancing and draining the  
 
superficial abscesses contaminates the skin and the surrounding  
 
environment. The unguided use of antibiotics increases the problem of  
 
antibiotic resistance. Thus, to combat the disease efforts should be directed  
 
to produce a protective vaccine against the disease.   
 
     Several vaccines were developed in order to find a reliable one for  
 
control the disease in sheep and goats. Different antigen were used but those   
 
vaccines showed varied degrees of protection. 
 
     The aim of this study was to determine prevalence of the disease among  
 
sheep and goats in South Darfur State and to produce mass culture of  
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C. pseudotuberculosis with IBT bioreactor to be used for vaccine  
 
production. 
   
    In this study physical examination by palpation of external lymph nodes  
 
of 6560 live sheep  and 4450 live goats revealed 34 (0.82%) and 54  
 
(0.76%) had enlarged lymph nodes in both of them respectively. In  
 
slaughtered sheep and goats  abscesses and pyogenic lesions due to C.  
 
pseudotuberculosis were found in 58 (1.7%) of 3324 carcasses of sheep and  
 
in 5(2.7%) of 184 carcasses of goats. Khalid(1971) reported  (7.4%)  
 
prevalence of CLA in slaughtered sheep  at Omdurman slaughterhouse,  
 
whereas Elgaddal (1997) reported a prevalence of 1.2% among live sheep  
 
and 3.2 % in slaughtered sheep due to C.pseudotuberculosis in the same area  
 
of our study. Higher prevalence rates of 6.4% and 7.1% in sheep and goats  
 
respectively were reported  in the same area by Musa (1998).  The lower  
 
prevalence rates observed in this study  might  be due to the increased  
 
awareness of animal traders about the disease and the selection of apparently  
 
disease free animals for he local markets and for export. They were informed  
 
that animal collected should not show abscesses.  
  
      Pure  C.pseudotuberculosis was isolated from58 (70.4%) of 89 lesions  
 
from sheep during meat inspection in Nyala slaughterhouse, this rate is  
 
higher than that stated by El gaddal (1997) who had isolated pure C.  
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pseudotuberculosis  from 51.8% sheep pus specimens at Nyala  
 
slaughterhouse, and also higher than that reported by Khalid (1971) who  
 
isolated C. pseudotuberculosis from 54.6% of 183 sheep abscesses  
 
collected from Omdurman slaughterhouse. Hence, our findings are  
 
supporting the idea that  C. pseudotuberculosis  is the predominant bacteria  
 
involved in sheep lymphadenitis and abscesses in the Sudan.  Yet, in  
 
Khartoum State many investigators (Hamad et al., 1992; Noura Karmalla,  
 
1997; Sara Bihary, 2002 and Nasreen Musa, 2009) isolated Staphylococcus  
 
spp.  from 73.9%, 96.5%, 48% and 68.8%  of sheep respectively. They  
 
attributed the increased prevalence rate of Staphylococcus. aureus subsp.  
 
anaerobius  in sheep abscesses in Khartoum State to the practice  of sheep  
 
fattening prior to slaughter or export. It is clear that C. pseudotuberculosis  is  
 
predominant in the production areas where seep and goats are grazed in  
 
common fields, whereas  S. aureus subsp. anaerobius is more frequently  
 
where animals are subjected to supplemented feeding for fattening in  
 
Khartoum State before slaughter.  This in turn may lead to the incrimination  
 
of substances in rations that are used for fattening  as a predisposing factors.  
 
Most sheep herders in Darfur and Kordofan believe that addition of salt  to  
 
rations  predisposes sheep to abscess formation. It is known that  
 
Staphylococci could tolerate up to 15% of salt concentration. Never the less,  
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this observation needs to be experimentally verified to put it in a scientific  
 
context, and then rations for sheep fattening could be modified for  
 
prevention measures.  
 
        In this study  it was found that the most frequently infected lymph node  
 
in sheep was the prescapular lymph node  and this is in agreement with  
 
many findings reported previously (Woodruff and Oxer, 1929; Gameel,1974;  
 
Khalid, 1971; Ayers, 1977; Williamson and Narin, 1980; Kuria and Nagatia,  
 
1990; Gilmour, 1990; Musa, 1998).  Elgaddal (1997) attributed the  
 
frequent occurrence of abscesses and pyogenic lesions in the prescapular  
 
lymph node to wounds caused by thorns and sharp objects during grazing in  
 
wooded Savannah pastures.  A total rate of 8.2%  of pus samples from  
 
carcasses or aspirated from live sheep were negative when bacteriologically  
 
cultured. This is lower than the 15% rate reported by Elgaddal (1997) but  
 
higher than the 5% and 2.9% rates  reported by Khalid (1971) and Hamad et  
 
al. (1992) respectively.  
 
          Confluent growth culture of C. pseudotuberculosis culture was  
 
successfully obtained using IBT bioreactor for the first time in Sudan, which  
 
showed the possibility of mass production of good quality culture and in  
 
short time. Our results were in agreement with those of  Sulieman (2001)  
 
using the same parameters (pH 8, temperature 31℃ and dilution rate 0.02 h-1 )  
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for  optimum growth of C. pseudotuberculosis  using IBT bioreactor with  
 
some modifications. 
 
     Five types of vaccines were tried to immunize sheep against  
 
CLA. The results showed that whole cell + toxoid (WC+T) was the most  
 
effective one among these vaccines. A significant reduction ( P< 0.05) in  
 
abscess formation was noticed after challenge with the C.pseudotuberculosis   
 
in sheep vaccinated with this vaccine compared with unvaccinated animals  
 
controls. The protection  percentage for the group vaccinated with this  
 
vaccine reached 75%  compared with  32.3%, 37.5%, 37.5% and 45.3% for  
 
groups vaccinated with cell wall, whole cell,  toxoid and cell wall + toxoid  
 
respectively. These results were in agreement with the findings of Simon- 
 
Valencia (1992) who reported that defatted whole cells of C.pseudotuber- 
 
culosis  with toxoid gave  best but not complete protection to challenged  
 
mice, and with those of  Burrell  (1978b) who  recommended the inclusion  
 
of bacterial cells in vaccines for control of CLA.  However,  Eggleton et al.  
 
(1991a) postulated that the addition of whole cells did not improve the  
 
protective potency of C. pseudotuberculosis toxoid vaccines, yet they  
 
illustrated that as the vaccine  which was used in their trials, had been  
 
prepared from crude toxoid, and could therefore contain soluble antigens  
 
other than exotoxin, their results did not preclude the possibility that more  
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than one antigen was responsible for the protection that had been conferred.  
 
        In a previous study it was found that cell wall + toxoid vaccine  
 
produced a protection percentage of 65.2% in goats (Abdel Wahab 2000),  
 
this rate is higher than the one observed in the present study in sheep(45.3%)  
 
using the same type of vaccine possibly due to species variation in  
 
immunological response.  
          
         In this study sheep vaccinated with toxoid alone ( T ) were  
 
susceptible to infection similar to the control animals. Five of seven animals  
 
in this group died   before challenge, i.e    only two animals remained which  
 
makes statistical evaluation of vaccination in this group unreliable.  
 
       In the present study the challenge dose of 5.1X108 CFU/ml of  C  
 
pseudotuberculosis inoculated subcutaneously was higher than the  
 
natural infection with C. pseudotuberculosis through the skin.  
 
C.pseudotuberculosis may be transmitted to sheep by contact of skin  
 
abrasions with contaminated soil or fomites (Hein and Cargill, 1981). A  
 
gram of pus may contain 106  to 107  CFU/ml of C. pseudotuberculosis  
 
(Augustine et al., 1982), however, as this pus becomes dried and dispersed  
 
in soil or on fomites, the concentration would decrease, therefore, a natural  
 
challenge dose would be  less than 5.1X108 CFU/ ml of C.pseudotuberculosis.      
 
       Death of control animals after challenge due to acute toxicity was  
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reported by Nairn et al. (1977). The results of this study confirm this  
 
observation as 3 animals in the control group died within 24 hours  
 
after challenge.    
 
      The development of suppurative lesions at the site of challenge in control  
 
and vaccinated animals with varied degrees was reported by Nairn et al.  
 
(1977) and our findings are in agreement with this. 
 
     Comparison of five serological tests, including agglutination test, for  
 
diagnosis of the disease, showed that no test was 100% specific and sensitive  
 
(Shigidi, 1979). In this study we used the bacterial agglutination test for  
 
monitoring the monitoring the humeral response in vaccinated then   
 
challenged animals, and the results obtained were similar to those of  
 
Shigidi(1979).  
 
         Results of  susceptibility of  C. pseudotuberculosis  to antimicrobial  
 
agents  were  in agreement with that of Lipsky et al. (1982) and Muckle and  
 
Gyles (1982, 1983) except that our isolates were resistant to penicillin. We  
 
agreed with Judson and Songer (1991) but disagreed with them in sensitivity   
 
to penicillins and resistance to nitrofurantoin. Our findings in agreement  
 
with those of  El gaddal (1997) and that reported by Musa (1998) but differ  
 
in that he found it sensitive to penicillins.  
  
         Resistance to penicillins is a growing problem which showed  
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in this study to reach 87.9%  this findings is similar to that reported by  
 
Grag et al., (1985). Location of the CLA organism inside macrophages  
 
suggests that lipophilic drugs such as the macrolides would be more  
 
effective than penicillins, and that prolonged administration would be  
 
required for effective treatment (Prescott and Baggot, 1988).  
 
           PCR targeting the 16S rRNA gene showed  positive results for  
 
all isolates previously known as C. pseudotuberculosis, and this is in  
 
agreement with  Çetinkaya et al. ( 2002),   putting in account that it could  
 
give the same results with C.ulcerans. This degree of similarity of C.  
 
pseudotuberculosis with C.ulcerans   was also noted by Barksdale et al.  
 
(1981) who reported that phospholipase D activity has been found in strains  
 
exhibiting the biochemical properties characteristic of C. pseudotuberculosis  
 
or of C.ulcerans and in no other species of Corynebacterium. Although C.  
 
ulcerans is known to cause diphtheria-like disease in humans and is also  
 
important in cattle, the presence of this species in small ruminants has not  
 
been noted in the literature. Some biochemical tests (trehalose, maltotriose),  
 
have been reported to distinguish C. pseudotuberculosis from C. ulcerans  
 
(Hommez et al., 1999). A multiplex PCR (mPCR) assay targeting three  
 
genes of this bacterium: the 16S rRNA gene, rpoB and pld  was developed  
 
by Pacheco et al. (2007) They reported that their mPCR assay was specific  
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enough to differentiate C. pseudotuberculosis from C. ulcerans. It was not  
 
possible to use  this method in this study due to difficulties in obtaining  
 
the  primers.  
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Chapter Five 
 
Conclusions and Recommendations 
 
 
Conclusions: 
 
From this study we came to the following conclusions: 
 
- Caseous lymphadenitis is prevalent in South Darfur              
 
State, West Sudan. 
 
       -    Accurate diagnosis for disease by palpation in live animals is not  
 
 possible, there is no 100% specific and sensitive serological test.  
 
In this study  PCR was used for characterization of  
 
C.pseudotuberculosis isolates, but the use of the new multiplex   
 
PCR for diagnosis of the disease by using blood will be more useful  
 
for its diagnosis. 
 
- The whole cell and toxoid vaccine produced with the       
 
      IBT bioreactor resulted in high degree of protection.  
 
- The causative organism (C. pseudotuberculosis) is sensitive to  
 
     nitrifurantoin, chloramphenicol, rifampacin, cotrimoxazole,  
 
     erythromycin, ampicillin.methicillin, kanamycin, gentamycin   
 
tetracycline  but resistant to nalidixic acid, colistin, novobiocin,   
 
penicillin, cloxacillin and streptomycin. It is clear that resistance to  
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penicillins emerged lately. 
 
              Recommendations:                                                                                                        
 
- Trials for using the whole cell +toxoid  vaccine  in the field under  
 
natural conditions for determination its efficacy in protection against   
 
CLA is recommended.  
 
     -     As it is evident that both of CLA and Morel’s diseases exist in  
      
      Sudan and should be dealt with simultaneously. A combined  
 
vaccine against them composed of this vaccine and other appropriate      
 
one against Morel’s disease  could be tried. 
  
- Careful use of antibiotics, infection control measures and periodic    
 
     surveillance for the antibiotic resistance studies could provide a useful     
 
     means  for controlling this disease. 
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